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Tuberculosis is a serious threat that claims 2 million lives annually. 
Mycobacterium tuberculosis is the causative agent of tuberculosis. The fast-growing 
bacteria Mycobacterium smegmatis is a model mycobacterial system, a non-pathogenic 
soil bacterium that nonetheless shares many features with the pathogenic M. tuberculosis. 
Multidimensional chromatography coupled with shotgun style tandem mass spectrometry 
was used to detect and identify 2,550 distinct proteins from M. smegmatis with an 
estimated 5% false positive identification rate, many predicted genes were annotated 
using experimental results and protein expression levels were estimated from the shotgun 
proteomic data.  
First, in 25 exponential and stationary phase experiments, we observed numerous 
proteins involved in energy production, protein translation, and lipid biosynthesis. Protein 
expression levels were estimated from the number of observations of each protein, 
allowing measurement of differential expression of complete operons, and the 
 vii
comparison of the stationary and exponential phase proteomes. Expression levels are 
correlated with proteins' codon biases and mRNA expression levels. 
Secondly, we measured changes in the proteome of Mycobacterium smegmatis in 
response to three anti-tuberculosis drugs isoniazid (INH), ethambutol (EMB) and 5-
chloro-pyrazinamide (5-Cl-PZA). Protein expression levels were calculated from the 
number of identified peptides for each protein. Translation, energy production, and 
protein export are all down-regulated in the three drug treatments. By contrast, systems 
related to drugs’ targets, including lipid, amino acid, nucleotide metabolism and 
transport, show specific protein expression changes associated with each drug treatment. 
We use these changes to infer likely targets for PZA. 
 Thirdly, computational methods were used to predict protein-protein interactions 
and protein functions in a metabolic pathway in M. tuberculosis. Protein functional links 
were built and specific functions were characterized for the pathway and its parallel 
pathways in M. tuberculosis and other organisms.  
Finally, multidimensional chromatography coupled with shotgun style tandem 
mass spectrometry has been applied in the analysis of nuclear proteins from mammalian 
cells. Nuclear proteins were identified from mouse T lymphoma cells. Nuclear matrix-
associated proteins were identified from human preliminary T cells during the transition 
from quiescent state to proliferating state. These proteins are involved in the function of 
DNA replication, RNA transcription, splicing, etc.  
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Chapter 1. Introduction 
 
Tuberculosis (TB) is one of the most prevalent infectious diseases in the world. 
Annually, there are eight million new cases and two million fatalities, according to the 
World Health Organization (http://www.who.int/tb/en). The cause of TB, Mycobacteria   
tuberculosis, is a slow-growing, aerobic gram-positive bacterium (Cole et al. 1998b). 
Although current first-line anti-TB drug regimens can achieve more than 99% efficacy, 
lengthy chemotherapy and emergence of drug-resistant strains pose significant problems 
for effective control (Corbett et al. 2003). Understanding the biological action of the 
currently used drugs will facilitate the discovery of new drugs that shorten and simplify 
the treatment of TB. 
 
The sequencing of the M. tuberculosis genome has accelerated progress in 
understanding TB (Cole et al. 1998b). DNA microarray technology has been used 
(Boshoff et al. 2004; Talaat et al. 2002; Wilson et al. 1999) to explore the function of 
genes and interactions between genes in M. tuberculosis under different growth 
conditions. As a complement to genomics data, proteomics has been widely used because 
biological activity is carried out mainly by the dynamic population of proteins (de Hoog 
and Mann 2004). A major goal of proteomics is quantitative analysis of all the proteins 
expressed in a cell or an organism under a specific condition (Pandey and Mann 2000). 
The proteome reflects the interaction and regulation between proteins and the functional 
status of a cell in response to environmental stimuli (Ong and Mann 2005).  
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Proteomics is built on technologies that analyze large numbers of proteins ——
ideally the entire proteome in the same experiment. Two-dimensional polyacrylamide gel 
electrophoresis (2DE) is the original high resolution protein separation method available; 
mass spectrometry is the most versatile technology to directly measure endogenous 
proteins. Two-dimensional gel electrophoresis coupled with mass spectrometry (2DE-
MS) was a popular analytical method used for profiling complete proteomes. Bypassing 
potential limitations of gel electrophoresis and protein insolubility, shotgun proteomics is 
a gel-free approach based on multidimensional liquid chromatography coupled to tandem 
mass spectrometry (LC/LC/MS/MS) (Washburn et al. 2001). In this method, protein 
mixtures are digested with proteases and the resulting peptides are separated by multi-
dimensional liquid chromatography, then the separated peptides are fragmented in the 
mass spectrometer and the MS/MS spectra are matched to predicted peptide sequences 
from a database (Link et al. 1999). Protein identification from the complex will be 
accomplished using SEQUEST (Eng 1994) or Mascot (Perkins et al. 1999) algorithm.  
 
Shotgun proteomics is capable of investigating the systematic response of 
mycobacteria in a reasonably comprehensive manner (Washburn and Yates 2000). The 
fast-growing Mycobacterium smegmatis, a non-pathogenic mycobacterial model system 
that shares many features with M. tuberculosis, has been used for the development of 
anti-mycobacterial therapy (Rapaport et al. 1996). The M. smegmatis grows faster is 
because there are two rRNA operons, while only one for M. tuberculosis (Ratledge 
1999). We applied LC/LC/MS/MS to characterize the expressed proteome of M. 
smegmatis, detect and identify approximately 2,550 distinct proteins, providing 
experimental annotation for many predicted genes with an estimated 5% false positive 
identification rate. In Chapter 2, we report the observation of 901 distinct proteins under 
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25 differing growth conditions, estimate protein expression levels from the number of 
observations of each protein, and demonstrate that the protein expression levels correlate 
with codon choice and mRNA expression levels.  
 
Proteomics is not only identification of proteins but characterization of protein 
expression levels. Quantitative proteomics provides an efficient way to accelerate the 
discovery and develop novel methods for disease therapy by systematically studying the 
proteome (Ong and Mann 2005). Changes in protein expression due to stimuli or 
conditioning are measured in a systematic manner and are used for elucidating 
mechanisms of cell function and signaling. A number of quantitative methods have been 
developed to measure protein expression levels from MS/MS data. Using stable isotopes 
as internal reference standards opened a new era for quantitative proteomics, such as 
Stable Isotope Labeling by Amino acids in Cell culture (SILAC) (Oda et al. 1999; Ong et 
al. 2002) and Isotope-Coded Affinity Tag Technology (ICAT) (Gygi et al. 1999). These 
methods provide a way to obtain relative quantification: each protein’s expression change 
is measured relative to the abundance of isotope labeled reference. In contrast, AQUA 
(Gerber et al. 2003) provides absolute quantification with the help of known amount of 
reference peptides spiked into a sample. These methods rely on peptide peak volume 
measurements for quantification. Absolute protein quantification can also be obtained 
from counts of the number of MS/MS spectra per protein, which can be related to protein 
expression level (Ishihama et al. 2005; Liu et al. 2004; Lu et al. 2005a). These emerging 
techniques for monitoring differential gene expression offer valuable guidance in 
elucidating regulatory mechanisms of metabolic pathways and thereby pinpointing new 
drug targets. This idea has been explored in our study of proteomic analysis of 
mycobacteria in response to anti-TB drugs. In Chapter 3, we treated Mycobacterium 
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smegmatis with anti-TB drugs Isoniazid (INH), ethambutol (EMB), 5-chloro-
pyrazinamide (5-Cl-PZA) (Zhang 2005), measured drug-induced alterations in M. 
smegmatis protein profiles, and identified markers of drug action. Protein differential 
expression levels were estimated from the shotgun proteomic data, and both individual 
proteins and families of proteins were identified that show altered expression levels in 
response to drugs. We provide a large-scale analysis of the M. smegmatis proteomic 
response to INH, EMB and 5-Cl-PZA and elucidate the drugs’ systematic effects on 
mycobacterial cells. 
 
Systematic characterization of protein functions and relationships can be obtained 
not only from the genome-wide experiments, such as shotgun experiments, but also from 
the information in genome sequences, such as patterns of gene fusion, conservation of 
gene order, patterns of gene co-inheritance and other sorts of evolutionary information, 
which can be revealed using computational methods (Eisenberg et al. 2000; Lee et al. 
2004; Marcotte et al. 1999b). In Chapter 4, we combined the methods of phylogenetic 
profiles, Rosetta Stone links, gene neighbor analysis and operon predictions to discover 
functional links between non-homologous proteins. These techniques are integrated with 
BLASTP (Altschul et al. 1990) and structure-derived protein functions to predict protein-
protein interactions, functions and metabolic pathways. We plotted a metabolic pathway 
in M. tuberculosis and assigned protein functions to the components of the pathway and 
the parallel pathways in M. tuberculosis and other organisms. This study on mycobacteria 
metabolic pathways sheds light on mechanisms of mycobacterial growth and drug 




Finally, in Chapter 5, we applied the LC/LC/MS/MS technique to the proteomic 
analysis of mammalian cells. In mouse T lymphoma cells, nuclear proteins were 
identified. In human primary T lymphocytes, the matrix-associated proteins involved in 
the transition from quiescent state to proliferating state were identified. These proteins 
are involved in the function of DNA replication, RNA transcription, and RNA splicing. 
These studies provide guidance in understanding how the nucleus functions and the role 
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Chapter 2. Mass-spectrometry of the M. smegmatis proteome: protein 
expression levels correlate with function, operons, and codon bias 
 
The fast-growing non-pathogenic bacterium Mycobacterium smegmatis is 
particularly useful in studying basic cellular processes of relevance to pathogenic 
mycobacteria, such as the related species M. tuberculosis, the causative agent of 
tuberculosis.  Although the genome sequencing of M. smegmatis is nearly complete 
(http://www.tigr.org) (Brosch et al. 2001), much is unknown about the mechanisms 
controlling growth in mycobacterial species. The large-scale study of the proteins 
expressed by M. smegmatis in different growth states has the potential to generate 
information about the mechanisms of cell growth, division, and adaptation, as well as 
inform about mycobacterial proteomes in general. 
 
Until recently, the method of choice for profiling a complete proteome was two-
dimensional gel electrophoresis coupled with mass spectrometry (2DE-MS). For 
example, using this approach, a total of 263 proteins were identified in M. tuberculosis 
and M. bovis BCG strains, the proteome of M. tuberculosis H37Rv was compared with 
that of M. bovis BCG Chicago, and twenty-five proteins differing in position or intensity 
were identified (Jungblut et al. 1999). Similarly, 137 proteins were detected in M. 
tuberculosis H37Rv culture supernatant, and 27 unique proteins were identified in M. 
tuberculosis H37Rv by comparing proteins in the culture supernatant of virulent M. 
tuberculosis H37Rv to that of attenuated M. bovis BCG Copenhagen (Mattow et al. 
2003). However, recent advances in multi-dimensional liquid chromatography coupled 
with tandem mass spectrometry (LC/LC/MS/MS) (Washburn et al. 2001) have produced 
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a technology capable of direct analysis of the composition of protein mixtures as complex 
as cell lysates (Aebersold and Mann 2003).  
 
Using this method, approximately 1,500 S. cerevisiae proteins were detected 
(Peng et al. 2003; Washburn et al. 2001). Similarly, in mycoplasma, Jaffe et al. detected 
557 open reading frames (ORFs) in M. pneumoniae strain M129 by using proteogenomic 
mapping, the mapping of peptides detected in the cell lysate onto the uninterpreted 
genome (Jaffe et al. 2004).  Here, we apply LC/LC/MS/MS to characterize the 
expressed proteome of M. smegmatis, and we report observation of 901 distinct proteins 
under differing growth conditions, estimate relative abundance of each protein. The 
protein relative abundance are correlated with codon choice and mRNA expression 
levels, as measured by comparison with codon adaptation indices, principal component 
analysis of codon frequencies and DNA microarray data. This observation is consistent 
with notions that either (1) prokaryotic protein expression levels are largely pre-set by 
codon choice, or (2) codon choice is optimized for consistency with average expression 






Experimental observation of 901 proteins in the M. smegmatis proteome and 
functions of the observed proteome 
Approximately 825,000 MS/MS peptide fragmentation spectra were collected and 
analyzed over the course of 25 LC/LC/MS/MS experiments, characterizing the proteins 
expressed in each of 25 samples drawn from time courses of M. smegmatis growing in 
three different media. At an estimated false-positive identification rate less than 5%, we 
identified a total of 901 M. smegmatis proteins (Figure 2.1).  These identified proteins 
represent ~10% of the 8,968 predicted genes identified in the unfinished M. smegmatis 
genome.  94% of the proteins were detected in more than one experiment, with a few 
proteins (2%) detected in every one of the 25 experiments.  
 
Each observed M. smegmatis protein was associated with a functional category by 
comparing the amino acid sequences (using BLASTP) to a database of 350,111 protein 
sequences from 89 fully sequenced genomes and transferring the broad-level Clusters of 
Orthologous Groups (COG) annotation (Tatusov et al. 2001) from the top-scoring 
homologs, where significant, to the M. smegmatis proteins.  The broad functions of the 
set of 901 detected proteins are plotted in Figure 2.1.  Major functions represented 
include energy production and conversion, amino acid transport and metabolism, 
translation, ribosomal structure and biogenesis, lipid transport and metabolism.  Roughly 
33% of the proteins could not be assigned functions in this manner (Figure 2.1).   
 
 
Figure 2.1  The distribution of the 901 proteins identifided across 25 LC/LC/MS/MS 
experiments. 
The distribution of observations of each of the 901 proteins (central chart) identified 
across 25 LC/LC/MS/MS experiments and the associated protein functions for the 
complete set of proteins (bottom chart), proteins detected in one to five of the 25 
experiments (top right chart), and the high abundance proteins detected in 20-25 of the 25 
experiments (top left chart). 
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The 901 proteins were ranked by the number of observations of each protein 
across the 25 experiments.  The set of proteins observed in 21-25 experiments, likely 
corresponding to highly expressed proteins, was significantly enriched for proteins 
involved in translation (30%), energy production (15%), small molecule transport and 
metabolism (18%), as well as a large fraction of uncharacterized proteins (15%).  
Examples of proteins in this set include peptidyl-prolyl cis-trans isomerase A (PpiA), 
glyceraldehyde 3-phosphate dehydrogenase (Gap), ATP synthase beta chain (AtpD), 
elongation factor Tu (Tuf), 60 kDa chaperonin (GroEL1), and 23 ribosomal proteins 
(e.g., RpsA, RplR). A number of these highly expressed proteins (3.6%) are involved in 
the metabolism of lipids, important components of the mycobacterial cell wall, 
accounting for ~60% of the cell wall weight (Ratledge 1999).  Highly expressed lipid 
metabolism proteins included acyl carrier protein (involved in meromycolate extension), 
acetyl-/propionyl-coenzyme A carboxylase (AccA3) and propionyl-CoA carboxylase 
beta chain 5 (AccD5), enzymes responsible for creating lipid structures in the cell wall. In 
addition to proteins involved in lipid metabolism, the enzymes necessary for glycolysis, 
the tricarboxylic acid cycle, and a large number of ribosomal proteins are also highly 
expressed, consistent with expectation.  
 
Focusing instead on proteins observed one to five times amongst the 25 
experiments reveals a very different trend. These proteins, probably representing low 
expression proteins, are substantially enriched for uncharacterized proteins, especially 
proteins whose broad function can be approximately assigned by homology (e.g., 
“dehydrogenase”), but whose specific function in M. smegmatis is unknown. The proteins 
involved in translation are substantially under-represented in this set.  The complete set 
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of protein identifications and growth phase expression levels are available as 
Supplemental Table 2.1. 
 
Proteomic observation of co-expression of operon-encoded proteins 
Given that operon-encoded proteins are co-transcribed and are generally co-
translated, we expect that proteins in the same operon should be co-expressed across the 
proteomic profiling experiments.  Figure 2.2 shows four such examples of proteins in 
the same operon coordinately expressed across the 25 experiments.  In each case, 
proteins encoded within the operon are observed, while proteins encoded by flanking 
genes and those on the opposite strand are not observed.  For example, Figure 2.2A 
shows AtpF, AtpH, AtpA, AtpG, AtpD and AtpC, subunits of the F0F1-type ATP 
synthase. Coexpression of these proteins reveals they are in the same operon while the 
neighboring genes and those encoded on the opposite strand, such as MSORF0600, 0602 
and 0604 are not detected.  
 
We see similar behavior for a uniquely mycobacterial system (Figure 2.2B): the 
genes that synthesize mycolic acid, the main component of the cell wall in mycobacteria 
and the end product in the metabolic pathway of InhA which is the primary target of 
mycobacterial drug isoniazid (Banerjee et al. 1994).  KasB (3-oxoacyl-[acyl-carrier-
protein] synthase2) is in the same operon as KasA (3-oxoacyl-[acyl-carrier-protein] 
synthase1), AcpM (acyl carrier protein), FabD (malonyl CoA-acyl carrier protein 
transacylase), and AccD6 (acetyl-/propionyl-CoA carboxylase). Both FabD and KasB are 
known components of the mycolic acid synthesis pathway (Wilson et al. 1999).  Figure 
2.2B shows that proteins encoded by the KasB operon are co-expressed, while proteins 
encoded by flanking genes are not.  
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Ribosomal proteins are often encoded in large operons to regulate ribosome 
synthesis (Allen et al. 1999).  Figure 2.2C shows that the RpsJ and RpsS operons, which 
are components of the 11 gene S10 ribosomal protein operon, produce large and small 
ribosomal subunit proteins; the proteins are strongly expressed in a coordinate fashion.  
  
Similarly, we observe an operon formed of antigen proteins (Figure 2.2D).  
MSORF5388 (ESAT6) and MSORF5389 (a homolog of Esat-6 protein family), identified 
in 17 and 19 experiments, respectively, are secreted antigens (Ratledge 1999). These two 
proteins are co-expressed with MSORF5386, an uncharacterized protein, suggesting that 
these three proteins form an operon, and by this association, may be functionally linked.  
Membership in the same operon argues that MSORF5386 may function with ESAT6 and 
MSORF5389. 
 
Correlation between protein expression levels and mRNA expression levels of 
orthologous genes 
We reason that the number of experiments in which a protein is observed 
(sampled) should roughly correlate with the protein’s expression level.  This assumption 
is based on the idea that in a LC/LC/MS/MS analysis of a cell lysate, which may consist 
of several hundred thousand tryptic peptides, only a subset of MS peaks are sampled for 
further MS/MS analysis, in total collecting ~30,000-40,000 MS/MS spectra per 
experiment. As the sampled peptides are typical chosen according to peak height in the 
MS parent spectra (here, choosing the 3 tallest peaks per MS spectrum), this introduces 
an intrinsic element of stochastic sampling and a bias towards high abundance proteins. 
Therefore, over repeated analyses, we expect to sample highly abundant proteins more
  
 
Figure 2.2  Proteins encoded in the same operon were observed to be coexpressed across 
the 25 experiments.  
All proteins observed in LC/LC/MS/MS experiments are labeled in bold, with arrows 
shaded according to the number of observations.  
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often and lower abundant proteins less often (e.g., as recently described in (Liu et al. 
2004).  In the analyses presented here, rather than repeated analysis of identical samples, 
we have analyzed related samples, thus this trend will be conflated with the tendency for 
a protein to be broadly expressed, rather than just highly expressed. Nonetheless, the 
general trend should hold.   
 
We wished to test our assumption that observation frequency will correlate with 
relative protein abundance.  As a first-order test of this idea, we compared the M. 
smegmatis protein observation frequency data with mRNA expression levels, under the 
assumption that protein and mRNA levels should be reasonably consistent.  For this test, 
we required an absolute measurement of mRNA expression levels, such as provided by 
Affymetrix style DNA microarrays.  As no such data is available for M. smegmatis prior 
to completing the genome sequence, we instead used data for the orthologous genes of E. 
coli grown under roughly equivalent conditions (exponential phase growth; (Covert et al. 
2004).  The number of observations of M. smegmatis proteins correlates moderately well 
with the absolute abundance of their E. coli orthologs’ mRNAs (R2 = 0.72, Figure 2.3).  
E. coli orthologs of proteins observed in all 25 experiments showed high mRNA 
expression levels (2313 +/-1126, arbitrary units from Affymetrix array data), while E. 
coli orthologs of proteins observed in only a single experiment were significantly lower 
(455 +/- 557; p-value < 0.001 by t-test). An ANOVA F-test of the simple linear 
regression between the mRNA abundance and number of mass spectrometry observations  
is significant (p<0.001).  These support the notion that the depth of sampling of a protein 




Figure 2.3  The number of observations for proteins correlates with mRNA expression 
level of E. coli orthologs.  
The number of experiments in which each protein was observed in exponential phase 
correlates (R2 = 0.72) with the corresponding mRNA expression levels, estimated from E. 
coli orthologs’ measured expression (Covert et al. 2004), suggesting that the depth of 





 Correlation between protein expression levels and the protein bias 
Because the number of observations of each protein correlates at least roughly 
with protein expression levels, we tested if these approximate expression levels were 
predictable from protein amino acid sequence properties.  First, we compared proteins’ 
expression levels to their codon biases, via the protein codon adaptation indices (CAI) 
(Sharp and Li 1987), which often correlate with protein expression level (Bennetzen and 
Hall 1982; Futcher et al. 1999; Gygi et al. 2000; Jansen et al. 2003; Sharp and Li 1987).  
As seen in Figure 2.4A, the proteins’ average CAI values are positively correlated (R2 = 
0.74) with the number of observations of each protein, suggesting the expression levels 
are indeed consistent with codon choice.  Proteins identified in all of 25 experiments 
typically showed high CAI values (CAI = 0.75 +/- 0.06) —examples include proteins 
involved in general metabolic pathways (e.g., PpiA, Gap, AtpD, Tuf, GroEL1 and RpsA) 
and specific metabolic pathways, especially lipid metabolism, such as acyl carrier 
protein, AccA3 and AccD5.  By contrast, proteins observed only in a single experiment 
showed considerably lower CAI values (CAI = 0.63 +/- 0.06), a significant difference in 
CAI under a t-test (p-value < 0.001).  
 
To further investigate the predictability of protein expression levels, we 
performed principal component analysis (PCA) of M. smegmatis proteins’ codon 
frequencies.  PCA is a technique for summarizing the major variation in data.  In PCA, 
the dimensionality of a data set is reduced by projecting the original data along new 
coordinate axes (the principal components) that capture the major trends in the data.  
Principal components (PC’s) are linear transformations of the original sets of variables, 
uncorrelated and ordered, with the first few PC’s containing most of the variation in the 
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original data set (Jolliffe 2002; Yeung and Ruzzo 2001).  Performing PCA on the codon 
frequency vectors associated with each protein in our experiments therefore reveals the 
major trends in codon choice among observed M. smegmatis genes.  While codon 
adaptation indices capture one aspect of codon bias, PCA should return the major trends 
in codon bias, regardless of whether these correlate with CAI. We tested the major PC’s 
for correlation with the number of observations of each protein.  The dominant PC 
(PC1) captured the background frequency of codons used by M. smegmatis and did not 
correlate with protein expression levels (data not shown).  However, the second largest 
PC (PC2) correlated well with protein expression levels (Figure 2.4B, R2 = 0.84), 
supporting the notion that protein expression levels are largely predictable by codon 
choice.  PC3 and PC4 are no longer correlated with expression level. R2 was calculated 
from the average values of protein expression levels for the number of observations, 
while ANOVA F-test was performed from the raw data. The association of both PC2 and 
CAI-derived codon bias with protein abundance are significant under an ANOVA F-test 
(p<0.001).  Thus, codon bias, as captured by CAI or PCA, can be used to predict 
approximate expression levels of M. smegmatis proteins. 
 
Growth-phase specific expression 
The physical and metabolic changes in mycobacteria during exponential and 
stationary phase are largely unknown.  As comparative proteomics has the potential to 
detect changes in the proteome, for example changes in abundance as well as post-
translational modifications such as phosphorylation and glycosylation (Link et al. 1999), 
we compared the proteins expressed in exponential and stationary growth phases (Figure 
2.5A). Exponential phase cultures showed a higher fraction of proteins associated with  
  
 
Figure 2.4  The approximate expression levels of each protein are predicted by two 
different measures of the codon bias.  
 
(A) The number of experiments in which each protein was observed (estimating protein 
abundance) correlates with the proteins’ codon adaptation indices (CAI; R2 = 0.74) 
indicating that the proteins’ average expression levels can be partially predicted from the 
choice of codons used for each protein. (B) The number of observations of each protein 
also correlates well with codon bias calculated by principal component analysis of the 
proteins’ codon frequencies. Here, we plot the number of observations of each protein (x-
axis) versus the projection of the gene’s codon frequencies onto the second principal 
component (y-axis) (PC2; R2 = 0.84), which best captures variation in codon choice 
between proteins with high and low expression levels.  In this case, PC2 is negatively 
correlated with protein abundance. 
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active growth, such as DNA replication, recombination and repair, transcription, and 
translation. In contrast, stationary phase cells show higher fractions of proteins involved in 
competition for limited nutrients, including energy production and conversion, inorganic 
ion and carbohydrate transport and metabolism and posttranslational modification.  
 
We were able to investigate more subtle differences in protein abundance between 
exponential and stationary phase by comparing the number of experiments in which each 
protein was observed in the two growth phases (Figure 2.5B and C).  In this analysis, we 
expected to find sets of proteins overrepresented in stationary phase, presumably in order 
to make cells more competitive with stresses in nutrient-starved culture, and we did 
indeed find many such proteins.  Among the proteins enriched in stationary phase cells 
was the transcriptional activator MtrA, which is also induced in M. bovis BCG upon entry 
into macrophages (Zahrt and Deretic 2000).  Other stationary phase enriched proteins 
were involved in carbohydrate or fatty acid metabolism (GlgC, PrpE, LpqG, LpqY), 
energy metabolism (Catalase, QcrC, PdhAB, and Ndh), and sugar transport (ribose ABC 
transporter, GntP, β-glucanase), or amino acid transport (ProV, 3-dehydroquinase).  
Regulatory proteins (PhoY2) were also identified, as well as proteins of unknown 
function.   
 
Among the proteins we identified as up-regulated in exponentially growing cells, 
a number share the same COG functions with proteins enriched in stationary phase but 
have different specific functions. For example, the sigma factor SigA is only detected in 
exponential phase—consistent with the result that SigA mediates enhanced growth of M. 
tuberculosis (Wu et al. 2004)—while other sigma factors are enriched in stationary phase, 
such as SigH. As sigma subunits of E. coli are differentially expressed according to the  
 
 




Figure 2.5 A comparison of the proteomes of exponential and stationary phase cells.   
(A) The overlap of identified proteins in exponential and stationary phases (left chart), 
showing the functions of proteins specific to exponential phase (top right chart) or 
stationary phase (bottom right chart). For clarity, proteins with uncharacterized functions 
are excluded from the pie charts.  (B) COG functions for the proteins differentially 
expressed in exponential and stationary phases. For the proteins in each COG category, 
we plot the mean difference in expression level, calculated as mean(Nexp,i – 3/2*Nstat,i), 
where Nexp,i and Nstat,i are the number of observations of protein i in exponential and 
stationary phase, respectively. Proteins of cell growth (translation, replication, etc.) are 
highly induced in exponential phase, while proteins of transport and energy production 
are highly induced in stationary phase. PTM, post-translational modification.  (C) A 2D 
histogram plots the distribution of protein abundances and differential expression 
between stationary and exponential phase cells. The bulk of proteins lie on the diagonal 





functions of the proteins they regulate (Ishihama 2000), it seems likely that SigA may be 
regulating housekeeping genes, while SigH regulates stationary-phase specific genes, 
such as stress response or transport genes (Kormanec et al. 2000; Thackray and Moir 
2003).  
 
In many cases the differentially expressed proteins were components of operons 
that were themselves differently expressed.  For example, the RpsJ, RpsS, and KasB 
operons are up-regulated in exponential phase, while the PdhABC, Ndh, and FadE 





Figure 2.6  Proteins in the same operon co-express in a growth-phase specific manner.  
The color scale represents the relative expression of the protein between exponential 
phase (red) and stationary phase (blue), calculated as (number of observations in 
exponential phase – number of observations in stationary phase * 3/2), where the factor 
of 3/2 is introduced to scale the number of stationary phase experiments to match the 
number of exponential phase experiments.  The KasB operon (A) and RpsJ, RpsS 
operons (B) are up-regulated in exponential phase; the PdhABC (C), Ndh operon (D) and 




The ability to rapidly annotate genome sequences is becoming increasingly 
important given the current pace of genome sequencing; equally important are methods 
for characterizing protein dynamics on a genome-wide scale.  In this study we 
demonstrate the suitability of coupled liquid chromatography-mass spectrometry to 
address both problems.  Earlier analysis of mycobacterial proteomes by 2DE-MS 
identified roughly 300 proteins (Jungblut et al. 2001; Mattow et al. 2003).  By contrast, 
LC/LC/MS/MS methods have proved capable of identifying ~1,500 proteins from yeast 
lysates (Peng et al. 2003; Washburn et al. 2001).  As applied here, tandem mass-
spectrometry (MS/MS) is biased in single experiments towards detection of abundant 
proteins (e.g., ribosomal proteins and heat shock proteins), but stochastically samples 
lower abundance proteins.  Repeated analysis of related samples therefore leads to 
detection of lower expression level proteins, such as cell division proteins and 
transcription factors, and allows us to identify and estimate relative expression levels of 
901 proteins from M. smegmatis.  The data provide experimental annotation of predicted 
genes, provide measurement of relative protein abundance changes across conditions, and 
demonstrate the correlation of protein abundance with mRNA expression levels and 
codon choice. 
 
One goal of this mass spectrometry based analysis was to provide experimental 
annotation of abundantly expressed proteins. In particular, a painstaking manual 
evaluation of each predicted gene was required for other mycobacterial genomes (e.g., M. 
tuberculosis H37Rv (Cole et al. 1998a)) in order to eliminate false positive gene 
predictions.  We expect, given the density of predicted genes and previous observations 
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of the performance of Glimmer2.0. on default settings (Delcher et al. 1999), that a 
significant fraction of the predicted genes are false positives.  Assuming similar gene 
density to M. tuberculosis or M. bovis BCG, we expect ~6,300 genes in M. smegmatis 
(David Graham, personal communication), suggesting that ~30% of the 8,968 predicted 
genes are false positives.  For example, genes predicted on the opposing strand to 
expressed proteins within the operons of Figure 2.2, such as MSORF1376 in the KasB 
operon, may be candidate false positive predicted genes.   
 
Note that unlike other applications, for the purpose of constructing a mass 
spectrometry reference database, we desire to minimize the false negative gene 
identification rate, even at the expense of increasing the false positive gene identification 
rate, to ensure that all representative sequences are present. These gene prediction errors 
are clearly undesirable for other purposes, but for mass spectrometry serve to minimize 
the false negative protein identification rate in the mass spectrometry experiment.  The 
extreme case of this strategy is to compare the MS/MS spectral data against raw, 
uninterpreted genomic sequence data (Arthur and Wilkins 2003), even without predicting 
genes (Jaffe et al. 2004).  In this mode, the false positive gene prediction rate is 
maximal; however, this minimizes the false negative protein identification rate, allowing 
previously unrecognized proteins to be identified.  Proteomics has previously helped in 
this manner: for example, of 263 proteins detected in M. tuberculosis H37Rv by 2DE-
MS, 6 were not previously predicted (Jungblut et al. 2001).  To aid in such future 
annotation studies, all raw mass spectrometry data have been deposited into the public 
domain in the Open Proteomics Database (Prince et al. 2004).  However, via this mass 
spectrometric approach, we are able to rapidly validate a significant subset of the 
predicted genes.  The fraction of the proteome we identified also provides a framework 
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for understanding the activity of pathogenic M. tuberculosis: in total, 709 (78.7%) of the 
901 proteins we detected have homologs in M. tuberculosis H37Rv, compared to only 
47.5% for the entire set of 8,968 predicted M. smegmatis proteins, or to 68% if we 
assume.  Thus, the expressed M. smegmatis proteome is enriched for proteins of 
relevance to M. tuberculosis. 
 
Beyond experimentally annotating expressed proteins, the frequency of 
observation of each protein gives an estimate of protein abundance. We took advantage 
of this data to estimate the correlation between codon bias and protein abundance. Such a 
correlation has previously been observed for high abundant proteins, for example, in two-
dimensional gel electrophoresis analysis of the yeast proteome (Futcher et al. 1999; Gygi 
et al. 2000).  In our hands, the M. smegmatis protein expression levels were predictable 
from the genes’ codon biases as calculated by codon adaptation indices, as well as by 
principal component analysis. Our data supports two models of prokaryotic protein 
regulation.  In the first, the condition under which a protein would be expressed is set by 
the action of transcription factors and regulatory proteins, but the quantity of the 
expressed protein is “pre-set” by its codon bias.  Under this view, regulation of a 
prokaryotic protein is simplified to deciding when to express it at a given time, with the 
actual amount of the protein synthesized being optimized over evolutionary time.  A 
perhaps more plausible, equally supported explanation is that codon choice has been 
optimized to be non-limiting.  That is, protein abundance is set in some fashion (e.g., 
translation initiation, promoter strength, etc.) and may be dynamically regulated, but 
rarely exceeds a characteristic expression level.  Codons might then face selective 
evolutionary pressure to optimize such that the codon choice is non-limiting for the 
normal range of each protein’s expression. This scenario would still produce a correlation 
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between codon bias and average protein abundance.  We note that these expression 
measurements could in principle be made more accurate through the use of isotope 
labeling approaches, such as the use of metabolic labeling of stable-isotope tags or ICAT 
(Gygi et al. 1999) for quantitative protein expression profiling (Flory et al. 2002), as used 
to quantitate 280 M. tuberculosis proteins (Schmidt et al. 2004).  
 
Numerous physiological and metabolic changes happen during the transition from 
exponential phase to stationary phase, and we capture some of these changes in the 
differential expression analysis.  Proteins involved in the pathways of DNA replication, 
recombination and repair, transcription, and translation show a higher fraction of proteins 
associated with active growth.  In accord with our results, UmaA1 (lipid biosynthesis) 
and ParA (functions in chromosome partitioning), which we observe enriched in 
exponential phase, have been reported to be down-regulated in M. tuberculosis in nutrient 
starved media (Betts et al. 2002). 
 
When cells enter stationary phase, many growth-related genes are down-
regulated; instead, the stationary-phase-specific genes are expressed, such as proteins 
involved in energy production and conversion, post translation modification and 
carbohydrate transport and metabolism (Figure 2.5A).  The PdhABC proteins are up-
regulated in stationary phase, consistent with their up-regulation in M. tuberculosis 
starved for nutrients (Betts et al. 2002).  We speculate Mpt53, an immunogenic protein 
induced only in stationary phase, the transcription factor MtrA, and several proteases 
(ClpP, MSORF2945, and MSORF8009, a zinc metalloprotease) up-regulated in 
stationary phase, may be important for stress response and therefore might also be 
important to the virulence of pathogenic mycobacteria.  Finally, we noticed the 
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enrichment of numorous uncharacterized proteins in stationary phase. Although their 
exact function remains unknown, these proteins are likely to be stress response proteins, 
heat-shock proteins, or other proteins involved in coping with the nutrient limitation and 
high cell density in this phase of growth, suggesting that future experiments directly 
monitoring the stress-response of mycobacteria may be useful in more precisely 
determining their functions. 
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MATERIALS AND METHODS 
Initial identification of M. smegmatis protein coding sequences 
The partially complete genomic sequence for M. smegmatis mc2155 was obtained 
from The Institute for Genomic Research (TIGR) through the website at 
http://www.tigr.org in the form of 15 sequence contigs, and protein encoding genes were 
predicted by searching with the gene-finding program Glimmer 2.0 using default settings, 
which minimize the false negative identification rate of coding sequences but increase the 
false positive rate (Delcher et al. 1999). A total of 8,968 genes were predicted and 
assembled into a searchable database for interpreting mass spectrometry peptide 
fragmentation spectra data using the program BioWorks 3.1 (ThermoFinnigan).  The 
predicted genes were functionally annotated by comparing the predicted amino acid 
sequences against those of 350,111 protein sequences from 89 fully sequenced genomes 
(downloaded from the Entrez genome database) using the program BLASTP and default 
parameters, and selecting the protein functional annotation of the top BLAST match 
when it surpassed a BLAST expectation value threshold of 1e-6.  A broad functional 
category was also assigned to each protein by selecting the COG database annotation 
(Tatusov et al. 2001) associated with the top BLAST hit, when significant. For clarity in 
all discussion, COG category N (“cell mobility”) was labeled “protein export”, as M. 
smegmatis is non-mobile and the M. smegmatis proteins in this category are 
predominantly involved in protein export and stress adaptation. 
 
Growth of M. smegmatis mc2155 and preparation of cell lysates 
 
 33
M. smegmatis mc2155 bacteria were grown with agitation at 37°C in minimal 
medium (Brosch et al. 2001; Chacon et al. 2002) and rich media (Middlebrook7H9 
medium and Luria broth (LB) medium) (Jacobs et al. 1991), collecting samples for 16, 6 
and 3 time points from Middlebrook7H9 medium, LB, and minimal medium respectively. 
Samples were centrifuged at 12,000g for 30 min, suspended in ice-cold lysis buffer 
(25mM Tris HCL pH7.5, 2.5mM DTT, 1.0mM EDTA, 0.02%(w/v) Brij35, 1X 
Calbiochem Protease Inhibitor Cocktail Set I (CPICSI) ) (1ml/g cell pellet), and disrupted 
by bead-beating with 1mm glass beads (Parish 2001; Primm et al. 2000). Cell lysates 
were clarified by centrifugation at 20,000g for 30 min, with typical protein concentrations 
of 10mg/ml. 
 
Preparation and LC/LC/MS/MS analysis of M. smegmatis peptides 
M. smegmatis soluble protein extracts were diluted in digestion buffer (50mM 
Tris HCL pH8.0, 1.0M Urea, 2.0mM CaCl2), denatured at 95°C for 15 min, and digested 
with sequencing grade trypsin (Sigma) at 37°C for 20 h. Tryptic peptide mixtures were 
separated by automated two dimensional-high performance liquid chromatography.  
Chromatography was performed at 2µL/min with all buffers acidified with 0.1% formic 
acid.  Chromatography salt step fractions were eluted from a strong cation exchange 
column (SCX) with a continuous 5% acetonitrile (ACN) background and 10 minute salt 
bumps of 0, 20, 40, 60, 80, 100, 150, 200, 300, 500, and 900 mM ammonium chloride 
(Figure 2.7).  Each salt bump was eluted directly onto a reverse phase C18 column and 
washed free of salt.  Reverse phase chromatography was run in a 60 minute gradient 
from 5% to 45% ACN, then purged at 95% ACN.  Peptides were analyzed online with 
electrospray ionization (ESI) ion trap mass spectrometry (MS) (Link et al. 1999; 
Washburn et al. 2001) using a ThermoFinnigan Surveyor/DecaXP+ instrument.  In each  
 
 
Figure 2.7 The MS spectra from 11 salt steps. 
The MS spectra from 11 salt steps (left plot), the salt concentration increases from the 
bottom to top. Each peak corresponds to one peptide.  
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MS spectra, the 3 tallest individual peaks, corresponding to peptides, were fragmented by 
collision-induced dissociation with helium gas to produce MS/MS spectra.   
 
Estimating the mRNA expression levels 
E. coli orthologs of M. smegmatis proteins were identified by using BLASTP 
under default settings and the bi-directional best hit method (Overbeek et al. 1999), only 
accepting hits with BLAST E-values less than 1e-10.  By this approach, 1,250 M. 
smegmatis predicted genes have E. coli K-12 orthologs. The mRNA abundance of each 
of these genes was calculated as the average abundance across three replicate Affymetrix 
DNA microarrays from (Covert et al. 2004), representing the mRNA abundance of E. 
coli K-12 MG1655 cells growing in M9 media in exponential phase.  
 
Calculation of codon bias 
The codon adaptation index (CAI) of each M. smegmatis open reading frame was 
calculated as in (Sharp and Li 1987).  A second estimate of codon bias was generated by 
performing principal component analysis (Jolliffe 2002; Yeung and Ruzzo 2001) of the 
codon frequencies associated with each of the 901 observed M. smegmatis proteins.  
Using a Perl program, a vector was created for each gene composed of the usage 
frequencies of each of the 61 possible amino-acid encoding codons.  Principal 
component analysis was performed on the resulting frequency vectors using the program 
Cluster (Eisen et al. 1998).  Projection of each gene’s frequency vector onto each of the 
principal components associated a set of numerical indices with each gene describing the 
major trends in the gene’s codon frequencies. 
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An error model for mass spectrometry proteomics data 
Proteins were identified from the resulting peptide MS/MS fragmentation spectra 
by searching against the custom M. smegmatis predicted protein database using the 
program BioWorks 3.1 (Xcorr >= 2.5) and filtering the results with selection criteria that 
minimize the false positive identification rate to less than 5%. Calculation of false 
positive identification rate was based on the following procedure: The amino acid 
sequences of each predicted protein encoded in the M. smegmatis genome were shuffled, 
thereby preserving the length and amino acid frequency distribution of each protein but 
not the amino acid order, and fragmentation spectra from the 25 LC/LC/MS/MS 
experiments were analyzed against the shuffled database by using the program 
BioWorks3.2.  For each protein identified, we calculated the sum of the BioWorks 
protein scores across the 25 experiments using either the correct or shuffled version of the 
database (Figure 2.8). At a protein score threshold corresponding to a 5% false-positive 
identification rate in the shuffled database, a total of 899 proteins were found. A similar 
analysis using DTASelect (Tabb 2003) identified 426 proteins versus 2 in the shuffled 
database, at a false positive rate of 0.5%. By this analysis, DTASelect therefore gives a 
lower false positive identification rate, with a higher false negative identification rate. 
Using either criterion gave a total of 901 M. smegmatis proteins identified at a false 
positive rate of ~5%. 
 
The mass spectrometry raw data from this study have been deposited in the Open 
Proteomics Database http://bioinformatics.icmb.utexas.edu/OPD, under accession nos. 
opd00007_MYCSM–opd00031_MYCSM. 




Figure 2.8 Estimating the protein identification error rate.  
The false positive protein identification rate (triangles; estimated by comparing MS/MS 
spectra against a mass spectrometry reference database of shuffled M. smegmatis 
proteins) is plotted as a function of total BioWorks score for each protein. At a false 
positive identification rate of ~5% (corresponding to proteins with total scores >20 across 







Aebersold, R. and M. Mann. 2003. Mass spectrometry-based proteomics. Nature 422: 
198-207. 
Allen, T., P. Shen, L. Samsel, R. Liu, L. Lindahl, and J.M. Zengel. 1999. Phylogenetic 
analysis of L4-mediated autogenous control of the S10 ribosomal protein operon. 
J Bacteriol 181: 6124-6132. 
Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local 
alignment search tool. J Mol Biol 215: 403-410. 
Arthur, J.W. and M.R. Wilkins. 2003. Using proteomics to mine genome sequences. 
Journal of proteome research 3: 393-402. 
Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K.S. Um, T. Wilson, D. 
Collins, G. de Lisle, and W.R. Jacobs, Jr. 1994. inhA, a gene encoding a target for 
isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227-230. 
Bennetzen, J.L. and B.D. Hall. 1982. Codon selection in yeast. J Biol Chem 257: 3026-
3031. 
Betts, J.C., P.T. Lukey, L.C. Robb, R.A. McAdam, and K. Duncan. 2002. Evaluation of a 
nutrient starvation model of Mycobacterium tuberculosis persistence by gene and 
protein expression profiling. Mol Microbiol 43: 717-731. 
Boshoff, H.I., T.G. Myers, B.R. Copp, M.R. McNeil, M.A. Wilson, and C.E. Barry, 3rd. 
2004. The transcriptional responses of Mycobacterium tuberculosis to inhibitors 
of metabolism: novel insights into drug mechanisms of action. J Biol Chem 279: 
40174-40184. 
Brosch, R., A.S. Pym, S.V. Gordon, and S.T. Cole. 2001. The evolution of mycobacterial 
pathogenicity: clues from comparative genomics. Trends Microbiol 9: 452-458. 
Chacon, O., Z. Feng, N.B. Harris, N.E. Caceres, L.G. Adams, and R.G. Barletta. 2002. 
Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on 
D-Alanine for Growth. Antimicrob Agents Chemother 46: 47-54. 
Cole, S.T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. 
Eiglmeier, S. Gas, C.E. Barry, 3rd, F. Tekaia, K. Badcock, D. Basham, D. Brown, 
T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. 
Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. 
Murphy, K. Oliver, J. Osborne, M.A. Quail, M.A. Rajandream, J. Rogers, S. 
 39
Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J.E. Sulston, K. Taylor, S. 
Whitehead, and B.G. Barrell. 1998. Deciphering the biology of Mycobacterium 
tuberculosis from the complete genome sequence. Nature 393: 537-544. 
Corbett, E.L., C.J. Watt, N. Walker, D. Maher, B.G. Williams, M.C. Raviglione, and C. 
Dye. 2003. The growing burden of tuberculosis: global trends and interactions 
with the HIV epidemic. Arch Intern Med 163: 1009-1021. 
Covert, M.W., E.M. Knight, J.L. Reed, M.J. Herrgard, and B.O. Palsson. 2004. 
Integrating high-throughput and computational data elucidates bacterial networks. 
Nature 429: 92-96. 
de Hoog, C.L. and M. Mann. 2004. Proteomics. Annu Rev Genomics Hum Genet 5: 267-
293. 
Delcher, A.L., D. Harmon, S. Kasif, O. White, and S.L. Salzberg. 1999. Improved 
microbial gene identification with GLIMMER. Nucleic Acids Res 27: 4636-4641. 
Eisen, M.B., P.T. Spellman, P.O. Brown, and D. Botstein. 1998. Cluster analysis and 
display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 
14863-14868. 
Eisenberg, D., E.M. Marcotte, I. Xenarios, and T.O. Yeates. 2000. Protein function in the 
post-genomic era. Nature 405: 823-826. 
Flory, M.R., T.J. Griffin, D. Martin, and R. Aebersold. 2002. Advances in quantitative 
proteomics using stable isotope tags. Trends Biotechnol 20: S23-29. 
Futcher, B., G.I. Latter, P. Monardo, C.S. McLaughlin, and J.I. Garrels. 1999. A 
sampling of the yeast proteome. Mol Cell Biol 19: 7357-7368. 
Gerber, S.A., J. Rush, O. Stemman, M.W. Kirschner, and S.P. Gygi. 2003. Absolute 
quantification of proteins and phosphoproteins from cell lysates by tandem MS. 
Proc Natl Acad Sci U S A 100: 6940-6945. 
Gygi, S.P., G.L. Corthals, Y. Zhang, Y. Rochon, and R. Aebersold. 2000. Evaluation of 
two-dimensional gel electrophoresis-based proteome analysis technology. Proc 
Natl Acad Sci U S A 97: 9390-9395. 
Gygi, S.P., B. Rist, S.A. Gerber, F. Turecek, M.H. Gelb, and R. Aebersold. 1999. 
Quantitative analysis of complex protein mixtures using isotope-coded affinity 
tags. Nat Biotechnol 17: 994-999. 
Ishihama, A. 2000. Functional modulation of Escherichia coli RNA polymerase. Annu 
Rev Microbiol 54: 499-518. 
 40
Ishihama, Y., Y. Oda, T. Tabata, T. Sato, T. Nagasu, J. Rappsilber, and M. Mann. 2005. 
Exponentially Modified Protein Abundance Index (emPAI) for Estimation of 
Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides 
per Protein. Mol Cell Proteomics 4: 1265-1272. 
Jacobs, W.R., Jr., G.V. Kalpana, J.D. Cirillo, L. Pascopella, S.B. Snapper, R.A. Udani, 
W. Jones, R.G. Barletta, and B.R. Bloom. 1991. Genetic systems for 
mycobacteria. Methods Enzymol 204: 537-555. 
Jaffe, J.D., H.C. Berg, and G.M. Church. 2004. Proteogenomic mapping as a 
complementary method to perform genome annotation. Proteomics 4: 59-77. 
Jansen, R., H.J. Bussemaker, and M. Gerstein. 2003. Revisiting the codon adaptation 
index from a whole-genome perspective: analyzing the relationship between gene 
expression and codon occurrence in yeast using a variety of models. Nucleic 
Acids Res 31: 2242-2251. 
Jolliffe, I.T. 2002. Principal component analysis. Springer. 
Jungblut, P.R., E.C. Muller, J. Mattow, and S.H. Kaufmann. 2001. Proteomics reveals 
open reading frames in Mycobacterium tuberculosis H37Rv not predicted by 
genomics. Infect Immun 69: 5905-5907. 
Jungblut, P.R., U.E. Schaible, H.J. Mollenkopf, U. Zimny-Arndt, B. Raupach, J. Mattow, 
P. Halada, S. Lamer, K. Hagens, and S.H. Kaufmann. 1999. Comparative 
proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG 
strains: towards functional genomics of microbial pathogens. Mol Microbiol 33: 
1103-1117. 
Kormanec, J., B. Sevcikova, N. Halgasova, R. Knirschova, and B. Rezuchova. 2000. 
Identification and transcriptional characterization of the gene encoding the stress-
response sigma factor sigma(H) in streptomyces coelicolor A3(2). FEMS 
Microbiol Lett 189: 31-38. 
Lee, I., S.V. Date, A.T. Adai, and E.M. Marcotte. 2004. A probabilistic functional 
network of yeast genes. Science 306: 1555-1558. 
Link, A.J., J. Eng, D.M. Schieltz, E. Carmack, G.J. Mize, D.R. Morris, B.M. Garvik, and 
J.R. Yates, 3rd. 1999. Direct analysis of protein complexes using mass 
spectrometry. Nat Biotechnol 17: 676-682. 
Liu, H., R.G. Sadygov, and J.R. Yates, 3rd. 2004. A model for random sampling and 
estimation of relative protein abundance in shotgun proteomics. Anal Chem 76: 
4193-4201. 
 41
Lu, P., C. Vogel, and E.M.E. Marcotte. 2005. An estimate of relative contributions of 
transcriptional and translational regulation by absolute protein expression 
profiling. submitted. 
Marcotte, E.M., M. Pellegrini, M.J. Thompson, T.O. Yeates, and D. Eisenberg. 1999. A 
combined algorithm for genome-wide prediction of protein function. Nature 402: 
83-86. 
Mattow, J., U.E. Schaible, F. Schmidt, K. Hagens, F. Siejak, G. Brestrich, G. 
Haeselbarth, E.C. Muller, P.R. Jungblut, and S.H. Kaufmann. 2003. Comparative 
proteome analysis of culture supernatant proteins from virulent Mycobacterium 
tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 
24: 3405-3420. 
Oda, Y., K. Huang, F.R. Cross, D. Cowburn, and B.T. Chait. 1999. Accurate quantitation 
of protein expression and site-specific phosphorylation. Proc Natl Acad Sci U S A 
96: 6591-6596. 
Ong, S.E., B. Blagoev, I. Kratchmarova, D.B. Kristensen, H. Steen, A. Pandey, and M. 
Mann. 2002. Stable isotope labeling by amino acids in cell culture, SILAC, as a 
simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 
376-386. 
Ong, S.E. and M. Mann. 2005. Mass spectrometry-based proteomics turns quantitative. 
Nat Chem Biol 1: 252-262. 
Overbeek, R., M. Fonstein, M. D'Souza, G.D. Pusch, and N. Maltsev. 1999. The use of 
gene clusters to infer functional coupling. Proc Natl Acad Sci U S A 96: 2896-
2901. 
Pandey, A. and M. Mann. 2000. Proteomics to study genes and genomes. Nature 405: 
837-846. 
Parish, T. and N.G. Stoker. 2001. Mycobacterium tuberculosis Protocols. Humana press. 
Peng, J., J.E. Elias, C.C. Thoreen, L.J. Licklider, and S.P. Gygi. 2003. Evaluation of 
multidimensional chromatography coupled with tandem mass spectrometry 
(LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome 
Res 2: 43-50. 
Primm, T.P., S.J. Andersen, V. Mizrahi, D. Avarbock, H. Rubin, and C.E. Barry, 3rd. 
2000. The stringent response of Mycobacterium tuberculosis is required for long-
term survival. J Bacteriol 182: 4889-4898. 
Prince, J.T., M.W. Carlson, R. Wang, P. Lu, and E.M. Marcotte. 2004. The need for a 
public proteomics repository. Nat Biotechnol 22: 471-472. 
 42
Rapaport, E., A. Levina, V. Metelev, and P.C. Zamecnik. 1996. Antimycobacterial 
activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant 
strains. Proc Natl Acad Sci U S A 93: 709-713. 
Ratledge, C.a.D., J. 1999. Mycobacteria molecular biology and virulence. Blackwell 
science. 
Schmidt, F., S. Donahoe, K. Hagens, J. Mattow, U.E. Schaible, S.H. Kaufmann, R. 
Aebersold, and P.R. Jungblut. 2004. Complementary analysis of the 
Mycobacterium tuberculosis proteome by two-dimensional electrophoresis and 
isotope-coded affinity tag technology. Mol Cell Proteomics 3: 24-42. 
Sharp, P.M. and W.H. Li. 1987. The codon Adaptation Index--a measure of directional 
synonymous codon usage bias, and its potential applications. Nucleic Acids Res 
15: 1281-1295. 
Tabb, D.L., McDonald, W.H., and Yates III, J.R. 2002. DTASelect and Contrast: Tools 
for assembling and comparing protein identifications from shotgun proteomics. J. 
Proteome Res. 1: 21–26. 
Talaat, A.M., S.T. Howard, W.t. Hale, R. Lyons, H. Garner, and S.A. Johnston. 2002. 
Genomic DNA standards for gene expression profiling in Mycobacterium 
tuberculosis. Nucleic Acids Res 30: e104. 
Tatusov, R.L., D.A. Natale, I.V. Garkavtsev, T.A. Tatusova, U.T. Shankavaram, B.S. 
Rao, B. Kiryutin, M.Y. Galperin, N.D. Fedorova, and E.V. Koonin. 2001. The 
COG database: new developments in phylogenetic classification of proteins from 
complete genomes. Nucleic Acids Res 29: 22-28. 
Thackray, P.D. and A. Moir. 2003. SigM, an extracytoplasmic function sigma factor of 
Bacillus subtilis, is activated in response to cell wall antibiotics, ethanol, heat, 
acid, and superoxide stress. J Bacteriol 185: 3491-3498. 
Washburn, M.P., D. Wolters, and J.R. Yates, 3rd. 2001. Large-scale analysis of the yeast 
proteome by multidimensional protein identification technology. Nat Biotechnol 
19: 242-247. 
Washburn, M.P. and J.R. Yates, 3rd. 2000. Analysis of the microbial proteome. Curr 
Opin Microbiol 3: 292-297. 
Wilson, M., J. DeRisi, H.H. Kristensen, P. Imboden, S. Rane, P.O. Brown, and G.K. 
Schoolnik. 1999. Exploring drug-induced alterations in gene expression in 
Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci U S 
A 96: 12833-12838. 
 43
Wu, S., S.T. Howard, D.L. Lakey, A. Kipnis, B. Samten, H. Safi, V. Gruppo, B. Wizel, 
H. Shams, R.J. Basaraba, I.M. Orme, and P.F. Barnes. 2004. The principal sigma 
factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo. 
Mol Microbiol 51: 1551-1562. 
Yeung, K.Y. and W.L. Ruzzo. 2001. Principal component analysis for clustering gene 
expression data. Bioinformatics 17: 763-774. 
Zahrt, T.C. and V. Deretic. 2000. An essential two-component signal transduction system 
in Mycobacterium tuberculosis. J Bacteriol 182: 3832-3838. 
Zhang, Y. 2005. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol 





Chapter 3. Proteomic analysis of drug treated Mycobacterium smegmatis 
 
Tuberculosis (TB) is one of the most prevalent infectious diseases in the world, 
claiming 2 million lives every year (Corbett et al. 2003). Lengthy chemotherapy and 
emergence of drug-resistant strains pose significant problems for effective control. In 
order to shorten the duration of TB therapy, novel drugs are needed against the causative 
agent of TB, Mycobacterium tuberculosis. Understanding the biological action of the 
currently used drugs should help in the development of new drugs. Isoniazid (INH), 
ethambutol (EMB), pyrazinamide (PZA) (Figure 3.1) are the front-line drugs currently 
used to treat TB (Zhang 2005). INH selectively inhibits the synthesis of mycolic acids, 
the main component of the waxy cell wall in mycobacteria (Mdluli et al. 1998). Both 
enoyl-acyl carrier protein reductase (InhA) and 3-oxoacyl-[acyl-carrier-protein] synthase 
2 (KasB) have been proposed as the primary targets of INH, which are involved in the 
type II fatty acid synthase (FAS II) system of mycobacteria for full-length extension of 
the meromycolate chain (Takayama et al. 2005). The target gene of EMB is arabinosyl 
transferase (EmbABC), which is responsible for the synthesis of the arabinan portion of 
arabinogalactan (AG) (Takayama and Kilburn 1989) and lipoarabinomannan (LAM) 
(Deng et al. 1995; Mikusova et al. 1995) in mycobacterial cell walls. PZA disrupts cell 
membrane function and depletes energy transport (Zhang 2005; Zhang and Mitchison 
2003). Relatively little is known about the targets of PZA, although fatty acid synthase 
(Fas) has been proposed as a potential target (Zimhony et al. 2000).  
 
Proteomics is capable of investigating the systematic response of mycobacteria in 
a reasonably comprehensive manner (Washburn and Yates 2000). Two-dimensional gel  
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Figure 3.1 Structures of anti-TB drugs. 




electrophoresis coupled with mass spectrometry (2DE-MS) was a popular analytical 
method used in proteomics study. A total of 263 proteins were identified in M. 
tubeculosis and M. bovis BCG strains (Jungblut et al. 1999). 108 proteins (Schmidt et al. 
2004) and 105 membrane proteins (Sinha et al. 2005) were identified in M. tuberculosis. 
MudPIT, multi-dimensional protein identification technology, combining multi-
dimensional chromatographic separation and mass spectrometric detection 
(LC/LC/MS/MS) (Washburn et al. 2001), has been proven to be very efficient for 
analysis of highly complex protein mixtures as cell lysates (Aebersold and Mann 2003). 
This technology can be used to do high-throughput analyses while retaining high 
sensitivity and highly reproducible performance. Using this technique, 1044 proteins 
were identified from three subcellular compartments in M. tuberculosis (Mawuenyega et 




Proteomics is rapidly evolving from analysis of global expression patterns toward 
characterization of differential expression. Protein profiles after exposure to drugs make 
it possible to classify compounds of unknown mechanism of action into similar groups, 
thereby elucidating the site of mechanism of action (Takayama and Kilburn 1989). This 
idea was explored in our work to study the dynamically changing proteome, to compare 
proteomic fingerprints of drugs, and to identify markers of drug action. The fast-growing 
Mycobacterium smegmatis is a non-pathogenic model system for studying the cellular 
processes of mycobacteria, such as the related pathogenic species M. tuberculosis. It has 
been used to study alterations in protein expression in anti-TB drug treatments 
(Takayama and Kilburn 1989; Zimhony et al. 2000). M. smegmatis is sensitive to INH, 
EMB, and PZA’s analog 5-Cl-PZA (Zimhony et al. 2000), but resistant to PZA. Using 
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LC/LC/MS/MS we analyzed and quantified the M. smegmatis protein profiles in response 
to INH, EMB, and 5-Cl-PZA, which allowed us to identify proteins and families of 
proteins that show altered expression levels and elucidate the drugs’ systematic effects on 






The growth of M. smegmatis cells are inhibited by anti-TB drugs 
To investigate the metabolic changes, protein expression was examined 
throughout a time course after adding the anti-TB drugs. The M. smegmatis mc2155 cells 
were grown at 37˚C to early log phase, anti-TB drugs were added, and cells were grown 
with agitation at 37˚C. At initial time points, cells appear normal, with increasing time 
cell growth slows. In the presence of 4 µg INH per ml, the growth rate of M. smegmatis 
was reduced, and at 8 µg/ml, INH completely inhibited growth. In EMB treatment, when 
EMB concentration is 1 µg/ml, the cell growth was reduced. Cell growth stops when 
EMB reaches 4 µg/ml. 5-Cl-PZA slows cell growth at a concentration of 25 µg/ml, 
although still doesn’t fully inhibit cell growth with 50 µg/ml, consistant with previous 
observations (Zhang and Mitchison 2003) (Figure 3.2).  
 
Proteins identified in LC/LC/MS/MS experiments 
Approximately 2,000,000 MS/MS peptide fragmentation spectra were collected 
and analyzed over the course of 33 LC/LC/MS/MS experiments, characterizing the 
proteins expressed in 33 samples drawn from time courses of M. smegmatis growing in 
three different drug (INH, EMB, 5-Cl-PZA) treatments. By integrating these data with 
890,000 MS/MS spectra from 27 untreated control experiments (Wang et al. 2005), we 
analyzed a total of 2,550 M. smegmatis proteins. Proteins were identified using 
ProteinProphet (Nesvizhskii et al. 2003) at an estimated false-positive identification rate 
of approximately 5%. These identified proteins represent ~40% of the ~6,500 genes 
expected in the M. smegmatis genome (personal comm. with David Graham), whose final  
 
Figure 3.2 Viability of M. smegmatis cells following INH (A), EMB (B), and 5-Cl-PZA 
(C) treatments.  
M. smegmatis mc2155 cells were grown in Middlebrook 7H9 medium. INH, EMB or 5-
Cl-PZA was added at the indicated concentration into cells in early-log-phase at the 0 
hour time point. Cells were further incubated and monitored for growth rates once every 
four hours. At times indicated, small portions of the cultures were removed and the cell 
density was determined by OD600.  
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sequence and annotation is currently underway at The Institute for Genomic Research 
(TIGR).  
 
The global protein expression response of M. smegmatis to anti-TB drugs  
 It has been observed that the number of MS/MS spectra associated with each 
identified protein in shotgun proteomics experiments correlates well with protein 
concentrations (Liu et al. 2004). We estimated the protein abundance for each protein in 
drug treated M. smegmatis cells using this approach (Supplemental Table 3.1). Protein 
expression profiles derived from the fraction of sequenced peptides per protein reveal that 
proteins were differentially expressed in each treatment (Figure 3.3). Proteins involved in 
drug target pathways generally cluster together in this analysis. INH target 3-oxoacyl-
[acyl-carrier-protein] synthase 2 (KasB) is in the same operon as 3-oxoacyl-[acyl-carrier-
protein] synthase 1 (KasA), meromycolate extension acyl carrier protein (AcpM), 
malonyl CoA-acyl carrier protein transacylase (FabD), and acetyl/propionyl-CoA 
carboxylase (AccD6) (Figure 3.5C). Proteins encoded by genes in this operon, which are 
involved in the FAS-II fatty acid synthesis pathway, are coordinately up-regulated when 
cells are treated with INH. Fatty acid synthetase (Fas), propionyl-coA carboxylase 
(AccD5) and acetyl-/propionyl-coenzyme A carboxylase (AccA3), proteins in the 
mycolic acid synthesis pathway, are also coexpressed in this cluster as might be expected 
from the general perturbation to mycolic acid synthesis. In EMB treatments, the inosine-
5’-monophosphate dehydrogenases GuaB1, GuaB2, and GuaB3 are up-regulated. 
Glutamine synthetase GlnA and GlnB are up-regulated in 5-Cl-PZA treatment, which 
might be explained by 5-Cl-PZA-induced amide production activating the L-glutamine 
catabolism pathway (Bugrim et al. 2004). 
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Operon-encoded proteins change expression levels coordinately  
With these relative expression values, we analyzed the expression of proteins 
encoded in the same operons. First, as a simple check that these data are informative for 
measuring expression levels, a comparison of the Pearson’s correlation coefficient 
between protein expression vectors versus the physical distance between the 
corresponding genes on the M. smegmatis genome reveals that the smaller the distance 
between genes oriented in the same direction, the higher the expression correlation 
(Figure 3.4), as expected for coordinately regulated genes. 
 
Second, we see reasonably high coherence in the protein expression patterns of 
proteins in the same operon (Figure 3.5). For example, the expression levels of the 
proteins AtpF, AtpH, AtpA, AtpG, AtpD, and AtpC, subunits of the F0F1-type ATP 
synthase, are consistent in the three drug treatments and untreated control (Figure 3.5A). 
Figure 3.5B shows that the proteins in the RpsJ and RpsS operons, components of the 11 
gene S10 ribosomal protein operon, are strongly down-regulated in all three anti-TB drug 
treatments in a coordinate fashion. This result may indicate that these three drugs actively 
inhibit protein translation in cells, or, more likely, may be a secondary effect of the cells 
dying.  
 
We searched for operons that were up- or down-regulated in specific drug 
treatments. The proteins encoded by the KasB operon are strongly up-regulated in INH 
treatment (Figure 3.5C). KasB, the target of INH (Banerjee et al. 1994) is in the same 
operon as KasA, AcpM, FabD, and AccD6, which are grouped into one co-expression 




Figure 3.3   
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Figure 3.3  Hierarchical clustering of M. smegmatis proteins identified across 60 shotgun 
proteomics experiments.  
The data set is the fraction of sequenced peptides for proteins identified more than 20 
times across 60 shotgun experiments. (A) Proteins were clustered into groups in different 
treatments, black bars on the right indicate induced protein expression in drug treatments. 
(B-F) Proteins with expression levels up-regulated in anti-TB drug treatments are 





Figure 3.4  Pearson’s correlation coefficient between identified proteins correlate with 
physical distance between genes oriented the same direction.  
Pearson’s correlation coefficient is calculated based on the fraction of identified peptides 
per protein across all 60 shotgun experiments. The distance is the number of base pairs 




Figure 3.5 Operon-encoded protein expression level changes coordinately in drug 
treatments.  
Proteins with red colors were identified in our experiments, and red bold proteins are in 
the same operon. Proteins in the ATPase operon (A) express consistently in all 
treatments; proteins in RpsJ, RpsS operons (B) are down-regulated in three drug 
treatments; the KasB operon (C), and the MhpD operon (D) are up-regulated in INH, 5-
Cl-PZA treatments; proteins in QcrABC operon (E) are down-regulated in EMB 
treatment. The y axes in column charts (right) represent relative protein abundance. 
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quantitative analysis of INH-induced proteomic changes (Hughes et al. 2006). These 
proteins are known to be in the mycolic acid synthesis pathway (Wilson et al. 1999), the 
main component of the cell wall in mycobacteria. We reason that the INH-induced up-
regulation of these enzymes in FASII system suggests the bacteria is up-regulating 
mycolic acid synthesis enzymes to counteract the inhibitory effects of INH. Similarly, 4 
hydroxy-2-oxovalerate aldolase (XylQ), acetyldehyde dehydrogenase (XylK), and 2-
keto-4-pentenoate hydratase (MhpD) are up-regulated in 5-Cl-PZA treatment (Figure 
3.5D). This operon is involved in secondary metabolite biosynthesis, transport, and 
catabolism (http://www.ornl.gov/); the operon’s specific induction in 5-Cl-PZA-treated 
cells may implicate this system or those functionally linked to it as PZA targets. The 
ubiquinol-cytochrome C oxidoreductase QcrABC operon is down-regulated in EMB 
treatment (Figure 3.5E); this protein complex is an integral membrane enzyme that 
catalyzes electron transfer from a quinol to a c-type cytochrome (Yu et al. 1995). 
 
Protein differential expression in M. smegmatis in anti-TB drug treatments  
To characterize the cellular response to anti-TB drugs, we measured differential 
expression of identified proteins by counting peptides identified from each protein. The 
significance of differential expression was calculated as a Z score from the difference in 
peptide coverage for a given protein between two experiments (Lu et al. 2005b). The Z 
scores of identified proteins across 32 experiments were calculated (Supplemental Table 
3.2), and proteins showing significant expression changes were chosen at the 99% 
confidence level ( | ). The differential protein profiles provide information on 





We evaluated this strategy by calculating differential protein expression for INH-
treated cells, then testing how the known targets in the mycolate biosynthesis pathway 
behaved. Figure 3.6 shows that mycolic acid biosynthetic proteins are effectively 
identified by this strategy. While most cellular proteins are in the range of |Z|<2, the 22 
mycolic acid biosynthetic proteins are predominantly with |Z|>2, with the majority up-
regulated. 
 
Using this strategy, we tested for proteins strongly up- or down-regulated in each 
drug treatment. Each significantly differentially expressed protein was associated with a 
functional category and the enrichment for each functional category was calculated. The 
enriched categories provide biological interpretation of the mass spectrometry-based 
measurement of differential expression. Functional enrichment for each drug treatment is 
shown in Figure 3.7. Translation, energy production, and protein export are all down-
regulated in the three drug treatments. These three drugs each inhibit cell growth (Figure 
3.7B), apparent in the interruption of basic cellular processes. INH up-regulates lipid 
transport and metabolism 1.2-fold (Figure 3.7A), as expected for cells whose fatty acid 
synthesis (FASII) and mycolic acid synthesis are inhibited by INH. Lipid transport and 
metabolism is also up-regulated in EMB and 5-Cl-PZA treatments, in accordance with 
previous observations (Takayama and Kilburn 1989; Zhang 2005; Zhang and Mitchison 
2003). In addition, amino acid metabolism and transport is up-regulated in the three drug 
treatments. Some functional categories are under-represented, such as transcription and 
cell wall biogenesis, possibly stemming not from drug action but from the incomplete 
sampling of low-abundance and membrane proteins by shotgun proteomics. 
  
 
Figure 3.6 Proteins in the INH target pathway tend to have higher |Z| scores in INH 
treatment.  
Solid circles represent proteins shown in INH treatment, empty triangles represent 





Figure 3.7 Protein expression levels change in drug treatments.  
Proteins were selected as significantly differential expressed with 99% confidence. (A) 
COG functions for the proteins differentially expressed in each drug treatment. Black 
bars represent up-regulated proteins (Z 2.58) in each drug treatment; grey bars represent 
down-regulated proteins (Z≤ -2.58). For the proteins in each COG category, we plot the 
relative difference in expression level, calculated as log (N
≥
 up, COGx /Nup /NCOGx /N), where 
N up, COGx, and Nup represent the number of up-regulated proteins with COGx function and 
up-regulated proteins in each drug treatment, NCOGx and N are the number of observed 
proteins with COGx function and the number of observed proteins for each drug 
treatment. PTM, post-translational modification. (B) The significant functional 
enrichments in hypergeometric distribution are shown in the plot. Proteins with red color 
represent the protein expression levels were up-regulated in drug treatments, proteins 
with blue color represent down-regulation.  
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Figure 3.8 presents a visual summary of the drug-induced differential expression 
of proteins. Across 32 experiments, we identified 485 proteins differentially expressed 
with 99% confidence ( | ). For each protein, a point is plotted within the triangle 
at a position signifying the relative enrichment of the protein across the treatments 
(Tringe et al. 2005). The relative peptide fractions in the three drug treatments were 
















, where Fractiondrug,i represents the fraction of 
identified peptides for the protein i in total peptides observed in the drug’s shotgun 
experiments. Proteins plotted in the middle of the triangle are equally abundant in all 
three drug treatments. Proteins sitting in one of the corners are highly induced in one drug 
treatment, and proteins that appear along one of the edges are induced in only two of the 
three drug treatments. 
 
The effect of INH  
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 Using Figure 3.8, we first summarize the proteins specifically induced in INH-
treated cells. Proteins plotted in the INH-specific corner are involved in the biosynthesis 
of mycolic acid (Mawuenyega et al. 2005) (Raman et al. 2005). These proteins include 
the INH targets KasB and enoyl-ACP-reductase (InhA) (Sinha et al. 2005). 
Alkylhydroperoxidase (AhpD, an element of the peroxiredoxin defense against oxidative 
stress), mycolic acid synthase (UmaA1), and acetyl-coA acyltreansferase (FadA2, 
involved in lipid degradation) are in the corner as up-regulated. In addition, proteins in 
FAS-II system, such as, KasA, AcpM, FabD, AccD6, polyketide synthase (Pks13), fatty-
acid-CoA ligase (FadD32), and 3-oxoacyl-[acyl-carrier-protein] reductase (FabG4), are 
up-regulated as expected in INH treatments. The increased protein production results in  
 
 
Figure 3.8 Specific protein expression enrichments in drug treatments.  
Three-way comparison of INH, EMB, and 5-Cl-PZA treatment in terms of protein 
relative abundance in M. smegmatis. Each dot represents relative abundance of a protein 
in three drug treatments so that proximity to a vertex is proportional to the level of 
enrichment in the respective sample. Colored squares are annotated proteins: red squares 
represent known proteins in INH pathway (mycolic acid synthesis pathway); blue squares 
represent proteins discussed in the results of the EMB experiments; green squares are 




the accumulated fatty acid pathway precursors. Fatty acid synthetase (Fas), which 
catalyzes the formation of long-chain fatty acids, is up-regulated. The isoniazid inducible 
protein (IniA) (Colangeli et al. 2005), essential for activity of an efflux pump that confers 
drug tolerance to both INH and EMB, is also up-regulated. INH up-regulates the enzymes 
in FASII system, as reflected in the proteomics data. It suggests that the induction of 
these proteins is the consequence of a regulatory feedback mechanism that bacteria up-
regulate mycolic acid synthesis enzymes to conteract the inhibitory effects of INH.  
 
Peroxidase/catalase (KatG), which activates INH, is strongly down-regulated. The 
end products mycolyltransferase (FbpA, B, C) of mycolic acid pathway, the three 
subunits of antigen85 / fibronectin-binding protein, are down-regulated, consistent with 
previous observations (Cabusora et al. 2005; Wilson et al. 1999). As a consequence of 
INH activity, mature mycolates are not produced and become progressively depleted.  
 
The effect of EMB  
Next, we summarize specific responses to EMB. EMB targets the mycobacterial 
cell wall. The target genes are arabinosyl transferases (EmbABC), which act on the 
polymerization of arabinose into the arabinan of arabinogalactan (AG) and 
lipoarabinomannan (Jungblut et al. 1999), the major polysaccharide of the mycobacterial 
cell wall (Deng et al. 1995; Mikusova et al. 1995; Takayama and Kilburn 1989). In our 
experiments, proteins involved in FASII system are up-regulated in EMB treatments such 
as KasB, Pks13, and Fas. In contrast, FbpA and FbpC are down-regulated, consistent 
with EMB indirectly inhibiting mycolic acid synthesis by limiting the availability of 
arabinan for the mycolic acids to attach to (David et al. 1989), and triggering a cascade of 
changes in the lipid metabolism of mycobacteria.  
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In Figure 3.8, proteins shown in the corner of EMB include 7 membrane proteins, 
such as penicillin-binding proteins (essential membrane-bound cell-wall synthesizing 
enzyme), aspartate racemase (cell wall biogenesis), transmembrane alanine and glycine 
rich protein (peptidoglycan biosynthesis), lipoprotein (lpqG), and transmembrane 
cytocheome C oxidase CtaC (aerobic respiration). In addition, maltooligosyltrehalose 
synthase (GlgY, involved in trehalose biosynthesis), enoyl-CoA hydratase (beta oxidation 
of fatty acids), and cystathionine/methionine gamma-synthase/lyase. Ferrochelatase 
(HemZ) is in the operon with two genes (mabA and inhA) involved in mycolic acid 
biosynthesis. Glutamyl-tRNA synthetase (GltS) and IMP dehydrogenase (GuaB1, Gua2, 
Gua3, involved in GMP biosynthesis) are up-regulated, as glutamate and cAMP are 
necessary for galactose to be incorporated into cell wall (Raychaudhuri et al. 1998). 
Glutamate-1-semialdehyde 2,1-aminonutase (HemL) is up-regulated can be explained as 
EMB can help the glutamate-efflux (Radmacher et al. 2005). Zinc metalloprotease, a 
lethal factor, is capable of cleaving members of the membrane-associated protein (MAP) 
kinase family in macrophages (Vitale et al. 1998). Monooxygenase (MSORF3583 and 
MSORF 2318) and oxidoreductase (lpdA and MSORF8662) are up-regulated due to the 
stress of the EMB treatment. The up-regulation of pyruvate carboxylase (Pca, an 
anaplerotic enzyme) might be because the anaplerotic reactions play important roles in 
the biochemical differentiation of mycobacteria into non-replicating stages 
(Mukhopadhyay and Purwantini 2000). 
 
The effect of PZA  
Finally, we summarize the specific responses to 5-Cl-PZA. PZA is a prodrug, 
which has to be activated in the cell. The active derivative of PZA is pyrazinoic acid, 
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which is preferentially accumulated in an acidic pH. Mutations in the gene encoding 
pyrazinamidase/nicotinamidase (PncA) cause resistance to PZA (Scorpio and Zhang 
1996). The accumulation of pyrazinoic acid results in the death of cells. Relatively little 
is known about the targets of PZA, although PZA inhibits L-tryptophan catabolism (Saito 
et al. 2000) and increases catabolism of L-glutamine (Bugrim et al. 2004). PZA blocks 
energy transport by disrupting membrane functions (Zhang 2005; Zhang and Mitchison 
2003). PZA has been shown to inhibit fatty acid synthesis (Boshoff et al. 2002; Zimhony 
et al. 2000) and PZA elevates the NAD+ levels in cells (Shibata et al. 2001).  
 
The proteins shown in the corner of 5-Cl-PZA include PzaA, a homolog of PncA, 
which is up-regulated, possibly indicating an activity related to PzaA’s function in 
activating PZA by hydrolyzing PZA to pyrazinic acid. Glutamine synthetase GlnA1 and 
GlnB, playing a central role in nitrogen metabolism and the formation of a poly-L-
glutamate/glutamine cell wall structure (Harth et al. 2000), are up-regulated in 5-Cl-PZA 
treatment, which are responsible for NH2+ and energy status (Bugrim et al. 2004). The 
up-regulation of urea amidohydrolase (UreA and UreC)  can be explained as these 
widely distributed proteins from microorganisms to vertebrates produce hydrogen 
peroxide plus aldehyde when catabolizing endogenous or xenobiotic amines (Carpene et 
al. 2005). In addition, MSORF2805 (Rv1626 ortholog, nitrogen regulation protein), 
cyanate lyase LlD1, formamidase, isocitrate dehydrogenase (Icd2), and Rv0462 ortholog 
(MSORF1225, involved in energy production) are up-regulated. Those proteins are 
involved in nitrogen regulation and energy metabolism. Amine oxidase, amino acid 
transport system protein, aminotransferase, and oxidoreductase are up-regulated. 
 
To further investigate PZA effects, we plotted the expression changes in the GO 
functional categories for the significantly differential expressed proteins ( | ) in 
the 5-Cl-PZA drug treatments (Figure 3.9). We expect the most enriched categories might 
correspond to the pathways of PZA drug targets. Among up-regulated proteins, 
carboxylic acid metabolism, organic acid metabolism, nitrogen compound metabolism, 
and amino acid metabolism are significantly over represented. In contrast, the GO 
pathways of protein biosynthesis and protein metabolism are significantly enriched 
among down-regulated proteins. It would appear from the proteomics data that PZA’s 
primary specific effects are to perturb cellular nitrogen metabolism, carboxylic acid, and 





    
  
 
Figure 3.9 The significant GO functional categories in proteins identified in 5-Cl-PZA 
treatments.  
Hypergeometric distribution was calculated on the proteins show significantly differential 
expression ( | ) in 5-Cl-PZA treatments. The y axis represents the log-scale of the 
P-values in hypergeometric distribution. Gray bars represent the GO functional categories 
for the significant up-regulated proteins; black bars represent the GO functional 






The rapid progress in proteomics technology makes large-scale study of 100’s to 
1000’s of proteins possible. In the present analysis, we used this technology to shed light 
on drug action. An important factor in developing a new drug is the criterion that the 
compound must provide selective inhibition of the intended target. Protein profiling is 
useful for this confirmation through comparison of protein expression profiles obtained in 
response to novel inhibitors with signature protein expression profiles of drugs of known 
modes of action.  
 
The shotgun proteomics data generated in the process also provides an efficient 
method for annotating the expressed proteome. In all, we provide experimental support 
for 2550 proteins (Figure 3.10). Their COG categories (Figure 3.10A) indicate significant 
enrichment for proteins of energy production (6.5%), amino acid transport and 
metabolism (6%), lipid transport and metabolism (4.8%), as well as a large fraction of 
uncharacterized proteins (44%).  There is a clear enrichment over random expectation 
(Table 3.1) in proteins of protein biosynthesis, amino acid biosynthesis and metabolism, 
nucleotide biosynthesis and metabolism, and carbohydrate metabolism. These set of 
proteins show depletion for DNA recombination and RNA transcription. Thus, additional 
proteomics evidence for these proteins could be generated by targeting transcription 
regulation proteins.  
 
For each protein identified, we calculated the number of identified peptides and 
examined the distribution of these values across the set of 2550 proteins (Figure 3.11). 
While the majority of proteins were observed a small number of times, an appreciable 
fraction of the proteins (35%) had 10 or more repeat observations of associated peptides, 
 
   
 
Figure 3.10 The distribution of observations for the 2550 proteins across all experiments 
and the associated protein functions for the complete set of proteins.  
(A) The distribution of observation of each of the 2550 proteins across identified across 




   
 
 
Figure 3.11 The total number of identified proteins is anti-correlated with the number of 
observed peptides.  
The x axis represents the number of all peptides sequenced for protein; the y axis 




GO_ID GO_annotation p(fraction) F(significance) 
Functional 
Enrichment
GO:0009058 biosynthesis 0.306084819 9.00E-13 1.399541409
GO:0006082 organic acid metabolism 0.142593731 2.53E-08 1.516309413
GO:0019752 carboxylic acid metabolism 0.141979103 3.22E-08 1.513355563
GO:0006520 amino acid metabolism 0.088506454 3.97E-08 1.679523273
GO:0006807 nitrogen compound metabolism 0.09956976 8.66E-08 1.615056723
GO:0006412 protein biosynthesis 0.063921328 9.28E-08 1.796972453
GO:0008652 amino acid biosynthesis 0.057775046 8.26E-06 1.684071305
GO:0044267 cellular protein metabolism 0.145052243 1.96E-05 1.378813559
GO:0019538 protein metabolism 0.145666872 2.42E-05 1.372995781
GO:0009117 nucleotide metabolism 0.045482483 0.000184143 1.634130752
GO:0005975 carbohydrate metabolism 0.072526122 0.000276921 1.471976638
GO:0006164 purine nucleotide biosynthesis 0.015980332 0.000497806 2.02952183
GO:0006092 
main pathways of carbohydrate 
metabolism 0.025814382 0.000585167 1.77985843
GO:0006163 purine nucleotide metabolism 0.017209588 0.000643284 1.963079151
GO:0006418 
tRNA aminoacylation for protein 
translation 0.012907191 0.000841035 2.093951094
GO:0009165 nucleotide biosynthesis 0.035648433 0.000843502 1.630032619
GO:0009152 purine ribonucleotide biosynthesis 0.012292563 0.002548035 1.978783784
GO:0006313 DNA transposition 0.019053473 0.999924318 0.1418483
GO:0006310 DNA recombination 0.038106945 0.999998691 0.2836966
GO:0006355 
regulation of transcription, DNA-
dependent 0.132145052 1 0.541992458
GO:0045449 regulation of transcription 0.133988937 1 0.54461939
GO:0006351 transcription, DNA-dependent 0.134603565 1 0.572251018
GO:0006350 transcription 0.136447449 1 0.574421719
 
Table 3.1 The significant enrichment of GO functional categories for proteins 
differentially expressed in drug treatments. 
The significance is calculated using a two-tailed binomial distribution, for rare GO 
functional categories with p <0.05, the significance is calculated based on Poisson 




=  , where n represents the total 
number of the identified proteins, k is the number of identified proteins with the 
functional category j, p is the fraction of proteins in the functional category j for the 
whole genome. The GO functional categories with significance F < (1/350) represent 





with the highest sampling observed for the protein Tuf, whose peptides we observed a 
remarkable 5603 times; other highly observed protein include GroEL2, Fas, AccA3, 
glycerol kinase 2 and GlnA1. As peptide counts can be used to estimate protein 
abundances (Lu et al. 2005b), these data indicate that, in principle, expression differences 
of up to 4 orders of magnitude might be measured by this approach. 
 
Proteomics includes not only protein identification but also protein quantification. 
Quantitative proteomics is capable of measuring protein expression levels and the 
differential expression of proteins. The quantitative proteomics provides us the valuable 
information on action mode of anti-TB drugs. In order to explore alterations in M. 
smegmatis protein profiles, we have, by using LC/LC/MS/MS, generated signature 
profiles of M. smegmatis in response to treatment with INH, EMB, and 5-Cl-PZA. The 
protein profiles of M. smegmatis during exposure to drugs are direct consequences of 
drugs. We expect the protein expression changes to predominantly reflect differential 
expression of metabolite biosynthetic enzymes. We have compared and contrasted the 
response profiles to the three drugs and distinguish between these treatments, thereby 
providing insight into the differences in the mechanisms of action of these three drugs. 
Drugs selectively induce changes in the expression of genes coding for enzymes that 
comprise the affected pathway, especially before a more generalized stress response 
ensues. 
 
We can reveal the full picture of each component in cells changes under different 
conditions. In INH treatment, proteins involved in mycolic acid synthesis pathway are 
up-regulated, however, some proteins are down-regulated, such as transporter proteins 
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FbpABC. We reason that the INH-induced up-regulation of enzymes in FASII system 
suggests the bacterium is up-regulateing mycolic synthesis enzymes to counteract the 
inhibition effects of INH. Induced proteins could be predicted to either compensate for 
inhibition of the target pathway or respond to the toxic effect of the drug, and we expect 
that the protein profiles can serve as a fingerprint of a given drug’s mode of action. In 
quantitative proteomic analysis of the INH-induced changes in Mycobacteria bovis 
(Hughes et al. 2006), the KasB operon, and bacterioferritin (BfrB), Antigen 84 (Wag31) 
are significantly up-regulated, while, D-alanine:D-alanine ligase (Ddla, involved in 
peptidoglycan biosynthesis) and acyl-ACP desaturase (Des2) are markedly down-
regulated. The resulting protein expression profiles would not only serve as a kind of 
signature of the drug used, but would, in the case of inhibitors whose modes of action are 
unknown, incriminate the affected pathways and perhaps the specificly targeted enzymes 
within the pathway, in EMB and 5-Cl-PZA treatments.  
MATERIAL AND METHODS 
Growth and drug treatment of M. smegmatis cells 
M. smegmatis mc2155 bacteria were grown with agitation at 37°C in 
Middlebrook7H9 broth (Difco, supplemented with 10% Middlebrook OADC 
enrichment , 0.2% glycerol and 0.05% Tween-80) to mid-exponential phase (Jacobs et al. 
1991). Cultures for experimental treatment were initiated by diluting 1:200 into fresh 
7H9 media and grown to early log phase (OD600 ≈ 0.3) with shaking in 5% CO2 
atmosphere at 37°C. Drug treatments were begun by adding filtered stock solutions of 
INH (10 mg/ml, sigma) or EMB (10 mg/ml, sigma) to achieve the following final 
concentrations 4, 8, 12, 16, 30 µ  for INH and 0.5, 1, 2, 4, 8 µ  for EMB 
(Wilson et al. 1999). Minimum inhibitory concentrations (MICs) were measured using 
the microbroth dilution technique (Parish and Stoker 1998). 5-Cl-PZA treatment was 
performed in Middlebrook 7H9-based medium adjusted to pH 5.6 with HCl when 
cultures were grown from OD600 0.2 (Phetsuksiri B 1999; Wade and Zhang 2004), with 
final 5-Cl-PZA concentrations of 25 and 50 . Samples were collected at selected 
intervals as in (Wilson et al. 1999). Other than 25 samples from (Wang et al. 2005), 2 
more untreated control samples were collected at OD600 of 1.9. Samples were 
centrifuged at 12,000 g for 30 min, suspended in ice-cold lysis buffer (25mM Tris HCL 
pH7.5, 2.5mM DTT, 1.0mM EDTA, 0.02%(w/v) Brij35, 1X Calbiochem Protease 
Inhibitor Cocktail Set I (CPICSI) ) (1ml/g cell pellet), and disrupted by bead-beating with 
1mm glass beads (Parish and Stoker 2001; Parish 2001; Primm et al. 2000). Cell lysates 
were clarified by centrifugation at 20,000g for 30 min, with typical protein concentrations 





Preparation and LC/LC/MS/MS analysis of M. smegmatis peptides 
M. smegmatis soluble protein extracts were diluted in digestion buffer (50mM 
Tris HCL pH8.0, 1.0M urea, 2.0mM CaCl2), denatured at 95°C for 15 min, and digested 
with sequencing grade trypsin (Sigma) at 37°C for 20 hr. Untreated control samples were 
analyzed as in (Wang et al. 2005). Tryptic peptide mixtures were separated by automated 
two dimensional-high performance liquid chromatography.  Chromatography was 
performed at 2  with all buffers acidified with 0.1% formic acid.  
Chromatography salt step fractions were eluted from a strong cation exchange column 
(SCX) with a continuous 5% acetonitrile (ACN) background and 10 minute salt bumps of 
5, 20, 60, and 900 mM ammonium chloride.  Each salt bump was eluted directly onto a 
reverse phase C18 column and washed free of salt.  Reverse phase chromatography was 
run in a 125 minutes gradient from 5% to 50% ACN, then purged at 95% ACN.  
Peptides were analyzed online with electrospray ionization (ESI) ion trap mass 
spectrometry (Corbett et al.) (Link et al. 1999; Washburn et al. 2001) using a 
ThermoFinnigan Surveyor/DecaXP+ instrument. For drug treated samples, gas phase 
fractionation (GPF) was used to achieve maximum proteome coverage and increase 
coverage of low abundant proteins (Yi et al. 2002). Three sequential LC/LC/MS/MS 
analyses were performed, spectra collected from different mass/charge (m/z) ranges 
(300–650, 650–1000, and 1000–1500 m/z) for data-dependent precursor ion selection. 
For each MS spectra, the 5 tallest individual peaks, corresponding to peptides, were 
fragmented by collision-induced dissociation with helium gas to produce MS/MS spectra. 





For peptide and protein identification purposes, we used a database of 8968 
potential M. smegmatis coding sequences described in (Wang et al. 2005). Proteins were 
identified from the resulting peptide MS/MS fragmentation spectra by searching against 
the custom M. smegmatis predicted protein database using the program BioWorks 3.1. 
The unique and total number of peptides for each identified protein in a given proteomics 
experiment were obtained using PeptideProphet (Keller et al. 2002) and ProteinProphet 
(Nesvizhskii et al. 2003),  thresholding the false positive protein identification rate to 




To estimate the abundance of each protein i, we employed the APEX technique 
(Lu et al. 2005b). We counted the number (ni) of identified peptides and calculated 
relative protein abundance fi for that experiment as fi = ni / N, where N is the total number 
of observed peptides (observed MS/MS spectra) in the experiment. Based on these 
measures of fi , for differential protein expression was calculated as a Z-score as 
,1 ,2
,0 ,0 1 ,0 ,0 2(1 ) / (1 ) /
i i
i i i i
f f
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where the numerator represents the difference in sampled proportions of protein i 










= ; and the denominator 
represents the standard error of the difference under the null hypothesis in which the two 
sampled proportions are drawn from the same underlying distribution with the overall 
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. In this analysis, we pooled results from 8 experiments each 
for INH, EMB, and 5-Cl-PZA treatments and untreated controls.  
 
Clustering of proteins by their expression profiles 
Protein expression profiles were calculated from the relative abundance (fi values) 
for proteins identified more than 20 times across the 60 shotgun proteomics experiments. 
Hierarchical clustering was performed on the mean-centered profiles; the Pearson’s 
correlation coefficient between the expression vectors was calculated from the relative 
abundance (fi values).  
 
Functional annotation of M. smegmatis proteins 
The custom M. smegmatis predicted protein database was functionally annotated 
as described in (Wang et al. 2005). The proteins were assigned functional categories with 
the COG database annotation (Tatusov et al. 2001) associated with their top BLAST hits 
against a database of 89 fully sequenced genomes. M. smegmatis proteins were also 
assigned with M. tuberculosis orthologs’ GO functional annotation. 
We calculated the enrichment of functional categories among proteins showing 
significant differential expression in drug treatments. Under the hypergeometric 
distribution, the probability of a functional category being present only at levels expected 
by random chance is calculated as 
min( , )
integrated instantaneous( | , , ) ( | , , )
M n
i k
P k n M N P i n M
=
= ∑ N ,  
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, N is the total population size, M 
is the number of proteins in the functional category j, n is the number of identified 
proteins showing significant differential expression in each drug treatment, and k is the 
overlap between M and n. COG functional categories with Pintegrated < (1/18) are selected 
as significant, as there are 18 COG categories in M. smegmatis. 
 
Using a two-tailed binomial distribution, we identify GO functional categories 
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= −∑ , where n represents the total number of the 
identified proteins, k is the number of identified proteins with the functional category j, p 
is the fraction of proteins in the functional category j for the whole genome. GO 
functional categories with F < (1/350) are selected as significant, as there are 350 GO 




= . For rare GO functional categories 
with p <0.05, we calculated the significance based on Poisson statistics as: 
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= ∑ , where n, k and p are defined as above. Again, GO 




The mass spectrometry raw data from this study have been deposited in the Open 
Proteomics Database http://bioinformatics.icmb.utexas.edu/OPD, under accession nos. 
opd00007_MYCSM–opd00031_MYCSM and opd00047_MYCSM–opd00081_MYCSM. 
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Chapter 4. A novel metabolic pathway in mycobacteria 
  
As numerous genomes have been fully sequenced in recent years, determining 
protein functions using genome sequences is the next target. The protein function, instead 
of the action of a single molecule, is the context of its interaction with other proteins in 
the cell (Eisenberg et al. 2000). We set up a system to predict protein interactions, 
construct new functional networks, and identify protein pathways (Marcotte et al. 1999b). 
The method involves three steps. First, application of several computational methods for 
detecting functional linkages to all pairs of genes. Second, combining all derived 
functional links and build a functional network from acting pairs of proteins. Third, map 
known gene functions onto the network and predict their metabolic pathways (Dandekar 
et al. 1998).  
 
This study was an exercise in assigning function to an uncharacterized pathway 
by purely computational approaches. An uncharacterized metabolic pathway in 
Mycobacterium tuberculosis that involves seven proteins (Figure 4.1) had previously 
been identified and was chosen as the subject of the study. It is known that Rv3741c and 
Rv3742c are probable oxygenase A and B subunits, respectively, Rv3848 is a probable 
membrane protein, what functions other proteins have and what metabolic pathway these 
proteins belong to are unknown. In order to detect functional linkages between these 
proteins, four computational methods were used in our research: phylogenetic profile 
method (Date and Marcotte 2003; Pellegrini et al. 1999), Rosetta Stone method (Enright 
et al. 1999; Marcotte et al. 1999a), gene neighbor method (Dandekar et al. 1998; 
Overbeek et al. 1999), and operon prediction method (Rison et al. 2002; Salgado et al. 

















Figure 4.1 The predicted metabolic pathway with seven M. tuberculosis proteins. 
 92
 93
methods discover functional links between non-homologous proteins, reconstructing 
pathways through the use of genome sequence data. These methods were integrated with 
BLASTP (Altschul et al. 1990) based on the protein homology and structure-derived 
protein functions to predict protein-protein interactions, functional relationships, and 
metabolic pathways. We plotted a metabolic pathway in Mycobacterium tuberculosis and 
assigned protein functions to the pathway components (Figure 4.2). This pathway might 
perform unusual amino acids synthesis, carbohydrate and lipid or cell wall metabolism; 
homologs of several components of this pathway were found in M. tuberculosis and other 








Protein functional links 
M. tuberculosis homologs for each protein were identified (Figure 4.2). For 
example, Rv2565 is homolog of Rv0104; Rv2566 and Rv2569c are homologs of 
Rv2409c; Rv2567 is homolog of Rv2410c and Rv2411c; Rv0565, Rv3083, and Rv3854c 
are homologs of Rv3741c and Rv3742c. There are functional links between these 
homologous proteins. The phylogenetic profile method can also be used in predicting 
protein-protein interactions, but it rests on entirely different assumptions from BLASTP 
(Pellegrini et al. 1999). A phylogenetic profile describes the pattern of presence or 
absence of a particular protein across a set of genomes. Proteins that operate together in 
the cell are inherited in a correlated fashion. If two proteins have the same phylogenetic 
profiles, it is inferred that two proteins are co-inherited and might have a functional link 
(Date and Marcotte 2003; Marcotte 2000; Marcotte et al. 1999b). The similarity between 
phylogenetic profiles for proteins can be represented by the mutual information scores. In 
Table 4.1, proteins with mutual information scores above 0.4 show they have similar 
phylogenetic profiles and indicates that they are functionally linked.  
 
The operon prediction method predicts whether or not a pair of neighboring genes 
are in the same operon by measuring the physical distance between the gene pair. 
Neighboring genes were found to be in the same operon with high probability if the 
distance between them is less than 40 nucleotides (Salgado et al. 2000). The result shows 
that the genes encoding proteins Rv2409c, Rv2410c, Rv2411c and genes Rv3740c, 
Rv3741c, Rv3742c form two operons, as all consecutive genes are separated by less than 
40 nucleotides. The genes encoding Rv3848 and Rv0104 are in different operons, both of 
  Rv2409c Rv2410c Rv2411c Rv2566 Rv2567 Rv2569c Rv3740c         Rv3741c Rv3742c Rv0565 Rv3083 Rv3854c Rv3848 Rv0104 Rv2565
Rv2409c   0.44 0.59 0.41 0.59   0.07 0.17        0.21 0.22 0.23 0.24 0.11 0.07 0.09
Rv2410c 0.44   0.48 0.53   0.48 0.07 0.18        0.22 0.24 0.25 0.26 0.13 0.09 0.09
Rv2411c 0.59 0.48   0.44   0.63 0.06 0.16        0.2 0.19 0.2 0.21 0.11 0.08 0.05
Rv2566 0.41 0.53 0.44   0.53   0.08 0.19 0.24 0.28      0.29 0.3 0.11 0.1 0.09
Rv2567 0.59     0.53   0.63 0.07 0.18        0.22 0.24 0.25 0.26 0.13 0.09 0.1
Rv2569c   0.48 0.63   0.63   0.06 0.16        0.2 0.19 0.2 0.21 0.11 0.08 0.05
Rv3740c 0.07             0.07 0.06 0.08 0.07 0.06   0.1 0.11 0.2 0.21 0.21 0.08 0.12 0.03
Rv3741c         0.17 0.18 0.16 0.19 0.18 0.16 0.1 0.4       0.09   0.11 0.04
Rv3742c    0.21 0.22 0.2 0.24 0.22   0.2 0.11 0.4         0.11   0.13 0.04
Rv0565 0.22 0.24 0.19 0.28 0.24 0.19 0.2           0.11   0.14 0.11
Rv3083 0.23 0.25 0.2 0.29 0.25 0.2 0.21           0.13   0.14 0.11
Rv3854c                 0.24 0.26 0.21 0.3 0.26 0.21 0.21 0.12 0.43 0.09 
Rv3848 0.11               0.13 0.11 0.11 0.13 0.11 0.08 0.09 0.11 0.11 0.13 0.12 0.16 0.19
Rv0104 0.07           0.09 0.08 0.1 0.09 0.08 0.12 0.11 0.13 0.14 0.14 0.43 0.16     
Rv2565 0.09                0.09 0.05 0.09 0.1 0.05 0.03 0.04 0.04 0.11 0.11 0.09 0.19 
1pqC               0.21 .26**             
1pqP               .22* 0.22             
 
Table 4.1 Phylogenetic profiles indicate functional links between pathway members.  
Each value represents the mutual information measurement of the similarity between two phylogenetic profiles. Values above 
~0.4 indicate two genes are functionally linked (cyan boxes). Stars represent highest scores for Rv3741c and Rv3742c to non-
monooxygenases in M. tuberculosis geneome; yellow boxes show the second highest score for Rv3742c. Both stars and yellow 
boxes indicate functional linkage. 
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which are composed of single gene. We predict that these proteins in the same operon 
have similar functions given that genes in a same operon tend to have similar functions or 
in the similar cellular pathway (Marcotte 2000; Salgado et al. 2000). In addition, the 
shorter the pathway distance (the number of distinct metabolic steps separating two 
enzymes), the smaller the gene intervals. For example, enzymes coded by nearby genes in 
E. coli genome are more likely than distant ones to be close in a biochemical pathway 
(Rison et al. 2002). Therefore, we predict that proteins encoded by the Rv2409c operon 
(including Rv2409c, Rv2410c, and Rv2411c) are close in a cellular pathway, as are the 
proteins encoded by Rv3740c operon (Rv3740c, Rv3741c, and Rv3742c). Furthermore, 
proteins in each operon may have similar physiological functions as well.  
 
In the Rosetta Stone method (Enright et al. 1999; Marcotte et al. 1999a), separate 
proteins A and B in one organism are sometimes expressed as a fusion protein in another 
species, implying proteins A and B might be linked in physiological function. In this 
manner, Rv2567 is a homolog of Rv2410c and Rv2411c; Rv0565, Rv3083, and Rv3854c 
are homologs of Rv3741c and Rv3742c. Therefore, we predict Rv2410c and Rv2411c are 
functionally linked by domain fusion, same as Rv3741c and Rv3742c. In the gene 
neighbor method (Dandekar et al. 1998; Overbeek et al. 1999), if the genes that encode 
two proteins are neighbors in the genome of other organisms, they tend to be functionally 
linked. Proteins Rv2409c, Rv2410c and Rv2411c and proteins Rv3740c, Rv3741c, and 
Rv3742c are connected within each group by conserved gene positions. Rv0104 and 
Rv2409c are functionally linked in this method as their homologs Rv2565 and Rv2566 
are encoded in the same operon.  
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Construction of novel pathways  
Taking results of individual functional links from the methods of BLASTP, 
operon prediction, phylogenetic profiles, Rosetta Stone, and gene neighbors, we combine 
a set of protein interactions into an extended cellular pathway (Figure 4.3). (1) Proteins 
Rv2409c, Rv2410c, and Rv2411c are functionally linked by conserved gene position, 
domain fusion, and operon prediction, as are proteins Rv3740c, Rv3741c, and Rv3742c. 
(2) Protein Rv2409c is connected to Rv0104 since they have conserved gene neighbors. 
(3) The group of Rv2409c, Rv2410c, and Rv2411c have similar phylogenetic profiles as 
group of Rv2566, Rv2567, and Rv2569c, as indicated by the high mutual information 
scores, which infers that these proteins are parallel pathways in M. tuberculosis. We 
found homologs of several components in M. tuberculosis and other organisms, so we 
infer that this pathway exists at least partially in these organisms, such as Caulobacter 
crescentus, Deinococcus radiodurans, Mycobacterium leprae, and Pseudomonas 
aerufinosa. 
 
Identification of the pathway functions 
Having demonstrated that these proteins are functionally linked, we want to infer 
the biological functions of these proteins. Structure motifs and evolutionary tracing 
provide functional information for proteins and which protein superfamily and structural 
model each protein belongs to (Table 4.2). Table 4.3 shows enzymatic functions for 
proteins predicted from the COG database (Tatusov et al. 2001). In Table 4.4, the 
metabolic pathways (KEGG pathway)(Kanehisa and Goto 2000) in which these proteins 







   
 
Figure 4.3 Parallel protein interaction pathways predicted in M. tuberculosis and other 
organisms.  
(A) Extended protein pathways in M. tuberculosis and other organisms. (B) Core 
pathways in M. tuberculosis. Proteins connected by black bars are encoded by genes in 
the same operon; proteins in the same-colored boxes are homologous to each other 
(which are in one column in A), non-colored boxes represent non-homologous proteins. 
Red lines show the mutual information scores are higher than 0.40; red dotted lines 
represent top high scores for Rv3742c. Green dotted line indicates that operon Rv2409c 
is functionally linked to Rv0104 by gene neighbor method. Protein Rv3742c is linked to 
the Rv2566 since the mutual information score between them is the highest one (0.24) for 
Rv3742c to non-monooxygenases in M. tuberculosis genome. Protein Rv3742c is linked 
to Rv2409c, Rv2410c, and Rv2411c as the mutual information scores between each pair 
are high. A closely related pathway in M. tuberculosis involves Rv2565, Rv2566, 




TB protein Function (from COGs and BLASTP) Domain 
Rv2409c Predicted intracellular enzyme; amino acid transport and metabolism   transglutaminase
Rv2566 Predicted intracellular enzyme; amino acid transport and metabolism  transglutaminase
Rv2569c Predicted intracellular enzyme; amino acid transport and metabolism  transglutaminase
Rv3848 Probable membrane protein 
Rv3741c Similar to probable monooxygenase; inorganic ion transport and metabolism  
Rv3742c Similar to probable monooxygenase; inorganic ion transport and metabolism 
Rv0565 Probable monooxygenase; inorganic ion transport and olism 
Rv3083 Probable monooxygenase; inorganic ion transport and olism 
Rv3854c Probable monooxygenase; inorganic ion transport and olism 
Rv0104 Signal transduction  cNMP-binding 
Rv2565 Nucleotide binding cNMP-binding 
Rv3239c 
  





















Possible similar to 1sig, crystal structure of A sigma70 








Rv3741c FAD/NAD(P)-binding domain No






NAD(P)-binding Rossmann-fold domains, 
Formate/glycerate dehydrogenase catalytic 
domain-like 








Pos ilar to 1tsl, tyrosyl-transfer RNA synthetase




Glutathione metabolism Rv2409c transglutaminase or glutamyltransferase can be involved in 
glutathione metabolism 
Rv2411c is a member of glutathione synthetase superfamily 
Selenoamino acid metabolism 
 
 
Transglutaminase or glutamyltransferase(like Rv2409c) involved in such 
metabolisms 
Cyanoamino acid metabolism
Taurine and hypotaurine 
metabolism 
Prostaglandin and leukotriene 
metabolism 
Pentose phosphate metabolism Rv2410c has sequence homologue with 1gal (Glucose oxidase), which is in 
pentose phosphate metabolism 
 Phenylalanine, tyrosine and 
tryptophan biosynthesis 
Rv3848 has predicted structural homology with 2tsl ( tyrosyl-transfer tRNA 
synthetase), which is involved in phenylalanine, tyrosine and tryptophan 
biosynthesis, aminoacyl-tRNA biosynthesis 
Aminoacyl-tRNA biosynthesis
Table 4.4 Metabolic pathways consistent with predicted enzymatic functions of proteins in the pathway. 
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there is no glutathione metabolism in M. tuberculosis (Cole et al. 1998b), therefore the 
protein encoded in the Rv2409c operon and the protein Rv0104 may take part in unusual 
amino acid synthesis, carbohydrate or complex lipid metabolism. A closely related 
pathway in M. tuberculosis may involve Rv2565, Rv2566, and Rv2567 as well as 
Rv2569c. Rv3741c and Rv3742c, both linked to the Rv2409c system, have similar 
phylogenetic profiles with lipoproteins lpqP and lpqC, respectively, therefore Rv3741c 
and Rv3742c might be involved in lipid or cell wall metabolism. Finally, we conclude 
that this pathway is involved in the biological pathway of unusual amino acid synthesis, 
carbohydrate and complex lipid/cell wall metabolism. Some parallel pathways in M. 
tuberculosis and other species were also identified. Rison et al. suggested that two 
parallel pathways might be chemistry conserved, co-factor substrate, or substrate binding 
conserved (Rison et al. 2002). Therefore, we propose those parallel pathways in each 





The functions and relationships between genes and proteins can be obtained from 
the genome-wide experiments, for example, mRNA expression in microarray experiment 
and protein expression in shotgun experiment, or small-scale experiments such as pull-
down experiment.  Patterns of gene fusion, conservation of gene position, gene co-
inheritance, and other types of evolutionary information can also be used to discover 
protein functions (Eisenberg et al. 2000). These computational methods are especially 
useful when there is insufficient or minimal experimental evidence.  
 
The main goal of our research is to find functions for hypothetical proteins and 
assign the unknown proteins to the metabolic pathway. The important question is how we 
predict protein interaction from genome sequence alone, which will speed the research 
and provide direction for specific proteins. Our combination of computational methods 
such as phylogenetic profiles, domain fusion, and gene neighbor, provides new 
information about functional relationships and hence goes beyond the capabilities of 
traditional sequence matching and makes it possible to predict protein-protein 
interactions from genome sequences. We began with a simple metabolic pathway with 
uncharacterized proteins in M. tuberculosis. Constructing metabolic pathways from 
combined computational methods allows the novel prediction of proteins functions that 
can not be inferred reliably from any single method. 
 
We characterized the metabolic functions of proteins and identified particular 
pathway functions. We predicted that this metabolic pathway is involved in the biological 
pathway of unusual amino acid synthesis, carbohydrate metabolism and complex 
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lipid/cell wall metabolism. Parallel pathways in M. tuberculosis and other species were 
also identified and proposed to be functional linked. Overlapping predictions among 
methods gives confidence in the methods ability to predict true links. This allows us to 
confidently predict functions for uncharacterized proteins that are linked to characterized 
proteins. Proteins are characterized according to different metabolic pathways. These 
characterized proteins allow further study of the parallel metabolic pathways in M. 




The methods we used to predict protein interactions and functions are shown in 
Figure 4.2. The methods of BLASTP, operon prediction, phylogenetic profiles, Rosetta 
Stone, and gene neighbors have been used to predict protein functional links. Homologs 
of proteins were obtained by comparing the amino acid sequences against the protein 
sequences nr database (http://www.ncbi.nlm.nih.gov) using the program BLASTP and 
default parameters, and selecting the protein homolog of the BLASTP match when it 
surpassed a BLASTP expectation value threshold of 10-6. Phylogenetic profiles were 
taken from (Date and Marcotte 2003), and mutual information scores between 
phylogenetic profiles were calculated as described. Operon structures were inferred from 
the distances between genes available through Entrez Genome 
(http://www.ncbi.nlm.nih.gov). Protein functions and pathway functions were inferred as 
follows: information about protein families was obtained from 
(http://maple.bioc.columbia.edu/pp/submit_meta.html). Functions of proteins were 
obtained from the COGs website ((Tatusov et al. 2001); 
http://www.ncbi.nlm.nih.gov/COG). Information about metabolic pathways was obtained 
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Chapter 5. Application of LC/LC/MS/MS on Proteome Analysis  
 
Hematopoietic cells have the ability to proliferate from quiescent state in response 
to antigenic responses. Cells change considerably during this process: the chromatin 
becomes less dense, the nucleoli appear, the volume of both the nucleus and the 
cytoplasm increases, and new mRNA and proteins are synthesized (Janeway et al. 2005). 
Much of the cellular regulatory machinery controlling this process is localized to the 
nuclear matrix; mediating control of both DNA replication and gene expression by 
providing a structural support and organizing the many protein factors involved 
(Anachkova et al. 2005; Stein et al. 2004). The nuclear matrix is a structure in the 
nucleus, generally consisting of a nuclear lamina and pore complexes surrounding an 
internal fibrogranular network of RNP proteins and residual nucleoli. It spatially 
organizes DNA, RNA, and proteins in the nucleus. This is important as distinct 
macromolecular complexes forming on the nuclear matrix are involved in DNA 
replication, repair, and recombination, as well as RNA polymerase II transcription, RNA 
processing and metabolism (Nickerson 2001). In human primary T lymphocytes, it has 
been found that a DNA origin recognition complex forms when the cells are in late G1 
phase and is spatially organized by being bound to the nuclear matrix (Lea et al. 2003).  
 
The rapidly evolving field of mass spectrometry-based proteomic investigation 
allows for the identification of novel proteins and the characterization of protein 
functions in different cellular compartments (Washburn et al. 2001). More than 480 
mouse plasma proteins in normal and 790 mouse plasma proteins in RcsX-tumor-bearing 
SJL mouse plasma were identified using the 1D-Gel-LC-MS/MS method (Bhat et al. 
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2005). 174 matrix-bound proteins were identified using LC/LC/MS/MS approach in the 
extracts of the Jurkat cell line (Mitulovic et al. 2004). In our study, LC/LC/MS/MS is 
used to identify proteins from samples and relative protein abundances are approximated 
from the rates of sampling by repeated injections of the same sample into the 
LC/LC/MS/MS (Wang et al. 2005), and the number of peptides identified for each 
protein as in Chapter 3.  
 
To investigate the mechanisms that control cell cycle transitions from G0→G1-
phase, we carried out protein expression profiling to identify “signatures” of cell cycle 
phase transitions. Nuclear matrix-associated proteins that are regulated during the G0→ 
G1-phase transition in human peripheral blood T cells were identified using 
LC/LC/MS/MS technology. The characterization of these proteins provides the 
foundation for analyzing the matrix-bound proteome of human primary haemopoietic 
cells and a comprehensive investigation of regulation mechanisms in the transition 
through the G0→G1-phase in haemopoietic cells. 
 
In a second study of mammalian nuclear protein, we report the proteomic 
characterization of the nuclear protein from mouse T lymphoma. The mammalian nucleus 
is a highly heterogeneous organelle, the most complex subcellular compartment 
containing the vast majority of genetic material and the site of all major genome 
regulatory processes (Gorski and Misteli 2005). It is estimated that 20% of cellular 
proteins are in the nucleus of mammalian cells (Simpson et al. 2000). We identify 116 
proteins by shotgun proteomics and demonstrate several classes of functional proteins 
located in the nucleus. This study will shed light on how the nucleus functions and 
provide an understanding of the molecular mechanisms involved in nuclear processes. 
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RESULTS 
Part I. Proteomic analysis of nuclear matrix-associated proteins in primary human 
T-lymphocyte activation 
We investigated the dynamics of the proteins that bind the nuclear matrix by 
analyzing T lymphocyte samples taken in the quiescent state G0 phase and in the active 
growth state G1 phase. Matrix-associated proteins were extracted by our collaborators at 
King’s College, UK (N. Shaun Thomas’s lab) and four different protein mixtures: G0-
matrix-bound, G0-matrix-free, G1-matrix-bound, and G1-matrix-free were prepared. The 
same biological samples were each analyzed 4 times using LC/LC/MS/MS, and matrix-
associated proteins present in primary T cells in G0 and G1 phase were identified. In total, 
613 proteins have been identified across all 16 shotgun experiments, with the false 
positive protein identification error rate at less than 2% (Supplemental Table 5.1).  
 
Of 404 matrix-bound proteins, 255 proteins become matrix-bound as cells 
progress from G0 to late G1 phase, while 67 proteins were bound in G0 that are not bound 
in G1 phase. Interestingly, the most enriched-proteins among these G0-specific proteins 
are methyl CpG binding protein 2 and lymphocyte-specific protein 1 (pp52). Many 
abundant matrix-bound proteins were identified: histone proteins (H1, H2A, H2B, H3, 
and H4) and non-histone proteins (DEAD box helicases enriched in G1-phase), hnRNP 
(C, U), snRNP (D1, D3, U1, U2, U3, U5, and U4/U6.U5 tri snRNP), nucleolar (e.g. 
NOP56, Nucleolin (enriched in G1-phase, apparently an angiogenesis marker)), and 
matrix proteins (Lamins, nuclear mitotic apparatus proteins (NUMA)). In all, 183 of the 
404 matrix-bound proteins were previously known to be nuclear. 
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Other interesting G1-enriched matrix-bound proteins include: WD repeat domain 
36, T-cell activation WD repeat protein, interleukin enhancer binding factor 2, nuclear 
factor of activated T-cells, 45-kDa, and nuclear factor NF-κB1. Importantly, a number of 
low abundance transcription factors were also identified from the samples. These proteins 
includes several SWI/SNF related transcription factors, transcription factor 3 (AML2, 
Acute myeloidleukemia 2 protein), proliferation-associated protein 2G4 (induced in G1 
and may help control replication), apoptosis antagonizing transcription factor (activates 
DNA synthesis in quiescent NIH-3T3 cells through HDAC1 displacement), NFAT, 
TRRAP transformation/transcription domain-associated protein (histone acetylase-
related), CCAR1 cell-cycle, apoptosis regulatory protein 1, and so on. These examples 
demonstrate that by purifying the nuclear matrix, low abundance proteins like 
transcription factors can be successfully observed using shotgun proteomics. 
 
We also identified splicing factors and transcriptional co-activators. These include 
splicing factors 1, 2, 3a, 3b and Arg/Ser rich 7 & 10, transcriptional co-activator p52/p75, 
bZip and n-pac. Some proteins present only in late G1 phase (including bZip, MCM3, 5, 6 
and 7, HDAC2, and DNA topoisomerase I) indicate that we are able to detect 
components of complexes that are induced or form during cell cycle entry. The identified 
matrix-associated proteins are involved in facilitating DNA replication, RNA processing, 
and RNA transport, among other functions. 
 
Matched controls of non-matrix proteins run in parallel accounted for 38% of the 
proteins identified, although it is unclear at present whether this is due to cross-
contamination or that certain proteins are present in both matrix and non-matrix protein 
pools. Abundant cytosolic proteins (glycolysis proteins, alpha and beta actin, tubulin, 
profilin, and heat shock proteins) were correctly identified as non-matrix proteins.  
 
Part II. Proteomic profiles of nucleus in mouse T lymphoma cells 
Nuclear proteins were analyzed using 4 sequential LC/LC/MS/MS experiments, 
and 848 proteins were identified in all these experiments with a false identification rate of 
less than 5%. Cytosolic proteins (also 4 experiments) were analyzed in parallel as the 
control for nuclear protein characterization. Proteins were assigned as nuclear using a Z-
score based on the number of peptides identified per protein in the nuclear and cytosolic 
experiments. 116 proteins are nuclear proteins with 99% confidence ( , single-
sided) (Supplemental Table 5.2). Figure 5.1 shows that the higher the Z value, the higher 




These nuclear proteins include histone deacetylase, DNA helicase, DNA methyl-
transferase, HMGB2, radixin, methyl-CpG binding protein, acidic nuclear 
phosphoprotein 32 family member B, tumor rejection antigen gp96, and TBP-interacting 
protein. Importantly, we also identified cell division cycle 2 homolog A, transcription 
factor Swi, and transcription elongation factor. In addition, we also detected abundant 
HnRNP proteins (A3, L, M, H2, R, I, U, K, H1), splicing factor 3b, snRNP (A, E, U2, B, 
D1), ubiquitin-conjugating enzyme, and valyl-tRNA synthetase 2. These results indicate 
that low abundance proteins such as transcription factors can successfully be identified by 
shotgun proteomics of the nucleus, although we observe better coverage of such proteins 





Figure 5.1 Mouse proteins with higher Z scores are enriched for nuclear proteins.  
The subcellular localizations for proteins were obtained from the DAVID web server at 
http://david.niaid.nih.gov/david/version2/index.htm . 36% of the significant proteins 
( ) are nuclear proteins; 100% for the proteins ( Z ). Proteins with higher Z 
scores have higher chance to be nuclear proteins, indicating that the Z score effectively 





Translation initiation factor 5A and translation elongation factor 1 were observed 
to be abundant in both nucleus and cytosol. Some cytosolic proteins were also identified 
in the nuclear sample, although it is unclear whether this is due to cross-contamination or 
that certain proteins are present in both nucleus and cytosolic pools, reflecting their 
ability to translocate between these compartments. These proteins are ELAV (embryonic 
lethal abnormal vision), proliferating cell nuclear antigen, endoplasmic reticulum protein 
Pdia3, zinc-finger proteins, matrin, septin, actin, protein phosphatase (Ppp1ca, Ppp2cb, 
Anp32b, Pnkp), cytochrome C, protein disulfide isomerase-related protein, vemintin, 
golgi coil-coiled protein Gcc1, heat shock proteins, dynein, and spectrin. This research 




The mass spectrometer preferentially samples the most abundant proteins; with 
repeated runs, lower abundant proteins are sampled stochastically, and relative protein 
abundance can be approximated from the rates of sampling. We can increase the “depth” 
of the analyses by repeated injections of the same sample into the LC/LC/MS/MS. 
Repeated injections of the same sample would identify more proteins because the 
complexity of the sample exceeds the mass spectrometer's capacity for a single analysis. 
However, the more important point is that many proteins are observed multiple times. 
The number of observations of a protein is proportional to the protein's absolute 
abundance (Wang et al. 2005). Therefore, multiple injections not only increase the 
coverage, they also provide approximate (order-of-magnitude) quantification, and we can 
detect differential enrichment of proteins from the sampling depth under different 
conditions.  
 
Shotgun proteomics is a powerful tool for global analysis of nuclear proteins, 
which provide significant new information on the important regulatory proteins. We 
apply shotgun proteomics to identify multiple components of nuclear matrix-associated 
complexes involved in biologically important processes that change through the G0→G1-
phase transition. The proteins identified in our study were predominantly either proteins 
of the nuclear matrix/cytoskeleton or those known to be associated with the matrix. Three 
proteins (Nucleolin, HDAC2, and MCM7) have been validated by western blotting 
(finished by members in Dr. Shaun Thomas’ lab). It should be noted that HDAC2 was 
not known to be induced during transition from G0 to G1-phase. These studies set up a 
platform for analyzing the matrix-bound proteome of human primary haemopoietic cells 
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MATERIAL AND METHODS 
Database 
A database of 27,960 human protein sequences was downloaded from Entrez 
Genome (http://www.ncbi.nlm.nih.gov). A shuffled version of the database was 
generated as follows: the amino acid sequences of each predicted protein encoded in the 
human genome were written in random order, thereby preserving the length and amino 
acid frequency distribution of each protein but not the amino acid order (as described in 
Chapter 2).  
 
A database of 25,371 mouse (Mus musculus) proteins was downloaded from 
Entrez Genome (http://www.ncbi.nih.nlm.gov). The subcellular localizations for proteins 
were obtained from the DAVID web server at 
http://david.niaid.nih.gov/david/version2/index.htm . 
 
Human primary T cells nuclear matrix-associated protein complexes preparation 
(performed by members of Dr. Shawn Thomas’ lab, King’s College, London) 
Approximately 3x107 quiescent human primary T cells were isolated from blood. 
Half of the cells were stimulated with anti-CD3/CD28 for 8 hours and collected 40 hours 
after the stimulation (Lea et al. 2003), so they enter mid/late G1 phase and the 
unstimulated cells remain in G0 phase. The matrix-associated proteins in the quiescent 
(G0) T cells and those in mid/late G1 T cells were extracted in ice-cold CSK buffer (10 
mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose, 1 mM MgCl2, 1 mM EDTA, 0.1% 
(v/v) Triton X-100, 0.1 mM ATP with cocktails of protease and phosphatase inhibitors) 
(Krude et al. 1996). The soluble (matrix-free) proteins were retained and the insoluble 
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nuclear matrix/cytoskeleton-associated proteins were washed twice using ice-cold CSK 
buffer.  
 
Mouse T lymphoma cells nuclear protein sample preparation (performed by Xin 
Yao, laboratory of Dr. Philip Tucker, UT-Austin) 
Approximately 3x107 mouse T lymphoma BW5147 cells were harvested, washed 
in PBS, and resuspended in 5ml buffer (10mM Hepes pH7.9, 1.5 mM MgCl2, 10mM 
KCl, 1mM DTT, protease inhibitors) for 10 min. Cells were pelleted (1,000g for 10 min) 
and resuspended in 2ml of the same buffer. Cells were then lysed using 10 strokes in a 
homogenizer and nuclei were pelleted (1,000g for 10 min), the supernatant was retained 
as the cytoplasmic protein sample. The wash and centrifugation steps were repeated once, 
centrifuging at 30,000g for 20 min. Nuclei were resuspended in 1ml buffer (20 mM 
Hepes pH7.9, 25% glycerol 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT, 
protease inhibitors), and homogenized (~30 strokes), and stirred on a magnetic stirrer for 
30-60 min. The lysed nuclei were centrifuged at 30,000g for 20 min) and the supernatant 
dialyzed against 150 volumes of buffer (20mM Hepes pH7.9, 20% glycerol, 100mMKCl, 
0.2mM EDTA, 1mM DTT, protease inhibitors) for 3-4 hours. Nuclear extracts were 
centrifuged (30,000g for 20 min) and the supernatants collected for analysis. 
 
LC/LC/MS/MS analysis 
The protein mixtures were diluted in digestion buffer (50mM Tris HCL pH8.0, 
1.0M Urea, 2.0mM CaCl2), trypsinized, and analyzed by LC/LC/MS/MS as described in 
Chapter 3. Gas phase fractionation (GPF) was used to achieve maximum proteome 
coverage and increase coverage of low abundant proteins (Yi et al. 2002). Three 
sequential LC/LC/MS/MS analyses were performed. Spectra from different mass/charge 
(m/z) ranges (300–680, 680–900, and 900–1500 m/z) were collected for data-dependent 
precursor ion selection; for each MS spectra, the 5 tallest individual peaks, corresponding 
to peptides, were fragmented by collision-induced dissociation with helium gas to 
produce MS/MS spectra. Fragmentation data from the three runs were combined for 




≥ ≥ ≥ ≥
For the human primary T lymphocyte samples, MS/MS fragmentation spectra 
were analyzed using the program TurboSequest/ BioWorks 3.1 and DTASelect software 
(selection criteria are 2 unique peptides/protein; Xcorr 1.8, 2.5 & 3.5 for +1, +2 
& +3 charged peptides). The false positive identification rate was estimated by searching 
fragmentation spectra against the shuffled human protein database (Wang et al. 2005). By 
this analysis, DTASelect gives a low false positive identification rate (<2%), presumably 
with a high false negative identification rate. We estimated protein abundances from the 
number of observations of each protein.  Proteins enriched in the nuclear matrix were 
identified by testing if the total number of observations in matrix-bound samples minus 
the total number of observations in matrix-free samples was greater than 0, indicating that 
the proteins are enriched in the matrix bound fractions relative to the matrix-free ones. 
Likewise, proteins enriched in G1-phase relative to G0 were identified by requiring the 
total number of observations in G1-bound samples minus the total number of observations 
in G0-bound samples to be greater than 0. 
 
For mouse T lymphoma nuclear protein complex samples, MS/MS fragmentation 
spectra were analyzed using the program TurboSequest/ BioWorks 3.1 and 
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ProteinProphet (Nesvizhskii et al. 2003). The numbers of identified peptides per protein 
were used to estimate the relative enrichment of the proteins in the nucleus, as described 
in Chaper 3. 
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Chapter 6. Conclusions 
 
Proteomics is the study of all proteins expressed by the genome. Shotgun 
proteomics mass spectrometry has ushered in comprehensive analyses of the proteome 
(Ong and Mann 2005). In this work, we described application of shotgun proteomics to 
several biological problems, primarily the mapping of the Mycobacterium smegmatis 
proteome. Using shotgun experiments coupled with the incomplete M. smegmatis 
genome sequence, approximately 2,550 distinct proteins were identified with ~ 5% false 
positive identification rate. Our study therefore provides direct experimental annotation 
for the M. smegmatis genome.  
 
Protein expression levels were calculated from the number of observations for 
each protein, and the number of identified peptides for each protein. In the first case, we 
measured differential expression of complete operons, and compared proteomes in the 
exponential and the stationary phases.  Expression levels are correlated with proteins’ 
codon biases and mRNA expression levels, as measured by comparison with codon 
adaptation indices, principal component analysis of codon frequencies, and DNA 
microarray data. We also compared the differential protein expression of the M. 
smegmatis in response to the three anti-tuberculosis drugs isoniazid (Sinha et al.), 
ethambutol (EMB), and 5-chloro-pyrazinamide (5-Cl-PZA), and elucidated the drugs’ 
systematic effects on mycobacterial cells. In conclusion, the protein profiling of M. 
smegmatis provides us a step toward deeper understanding the mycobacteria growth and 
guidance for deciphering the biology of Mycobacterium tuberculosis. Quantitative 
analysis of proteome of M. smegmatis gives a platform for discovering the mechanism of 
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drug responses and a tractable system for anti-mycobacterial drug development. The 
shotgun technology has been a core tool for proteomics study. Although we identified 
100 to 1000 proteins in each experiment, far more spectra have not been identified, which 
requires the improvement of the data analysis tools (Prince et al. 2004). The application 
of statistics in qualitative and quantitative proteomics will pave the way for the functional 
studies (Ong and Mann 2005).  
 
Computational methods are helpful in predicting protein-protein interactions and 
assigning functions to proteins in M. tuberculosis. The methods of phylogenetic profiles, 
domain fusions, gene neighbors, and operon predictions, combined with BLASTP, 
discover protein functional links and characterize specific functions for the metabolic 
pathway and parallel pathways. However, computational methods depend on the genome 
sequences and knowledge for the protein functions, error is unavoidable as there are 
incomplete sequences and misannotated proteins. Therefore, molecular biology 
experiments are still required for the verification of the predicted protein functions. 
 
The shotgun technology has also been applied in the proteomic analysis in 
mammalian cells. The matrix-associated proteins have been identified from the human 
preliminary T cells during cell activation. These proteins are involved in DNA 
replication, RNA transcription, splicing, and so on. Nuclear proteins have been identified 
from the mouse T lymphoma. Instead of analyzing entire proteomes, the analyzation of 
subcellular fractions of particular biological interest is a more efficient and practical 
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